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ABSTRACT 
The sensitive, selective, and practical detection of aliphatic alcohols is a continuing 
technical challenge with significant impact in public health work and environmental 
remediation efforts. Reported in the first manuscript is the use of a β-cyclodextrin 
derivative to promote proximity-induced interactions between aliphatic alcohol analytes 
and a brightly colored organic dye, which result in highly analyte-specific color changes 
that enabled accurate alcohol identification. Linear discriminant analysis of the color 
changes enabled resulting in 100% differentiation of the colorimetric signals obtained from 
methanol, ethanol, and isopropanol in combination with BODIPY and Rhodamine dyes. 
The resulting solution-state detection system has significant broad-based applicability 
because it uses only easily available materials to achieve such detection, with moderate 
limits of detection obtained. Future research with this sensor system will focus on 
decreasing limits of detection as well as on optimizing the system for quantitative detection 
applications.  
Reported in Chapter 2 of this thesis are our efforts towards the development of similar 
cyclodextrin-based systems for the detection of anabolic steroids that are of interest in 
illegal doping scandals. These systems, in close analogy to other systems developed in our 
group, rely on the fact that combining the target analytes with a high quantum yield 
fluorophore results in a measurable, analyte-specific change in the fluorophore emission 
signal. Promising results were seen in our solution-state detection of anabolic steroids via 
the use of β-cyclodextrin derivatives as supramolecular scaffolds and Rhodamine 6G as 
the signal transducing element. Using linear discriminant analysis, arrays were generated, 
illustrating the differentiation and classification of the analytes with high selectivity in the 
system. Limits of detection falling below the micromolar range show a high sensitivity of 
 
 
the system. Current efforts are focused on improving the reproducibility of these 
experiments to enable a high functioning detection system as well as efforts toward moving 
to a solid-state detection system. 
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PREFACE 
This thesis is presented in manuscript format according to the guidelines of the graduate 
school of the University of Rhode Island. Two manuscripts will be presented in this thesis. 
Chapter 1 is published in ACS Omega with authors Anna Haynes, Priva Halpert, and Mindy 
Levine. Chapter 2 is being submitted for publication to RSC Advances with authors Anna 
Haynes and Mindy Levine. 
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ABSTRACT 
The sensitive, selective, and practical detection of aliphatic alcohols is a continuing 
technical challenge with significant impact in public health work and environmental 
remediation efforts. Reported herein is the use of a β-cyclodextrin derivative to promote 
proximity-induced interactions between aliphatic alcohol analytes and a brightly colored 
organic dye, which result in highly analyte-specific color changes that enabled accurate 
alcohol identification. Linear discriminant analysis of the color changes enabled resulting 
in 100% differentiation of the colorimetric signals obtained from methanol, ethanol, and 
isopropanol in combination with BODIPY and Rhodamine dyes. The resulting solution-
state detection system has significant broad-based applicability because it uses only easily 
available materials to achieve such detection, with moderate limits of detection obtained. 
Future research with this sensor system will focus on decreasing limits of detection as well 
as on optimizing the system for quantitative detection applications. 
INTRODUCTION 
Increased interest in using non-mass spectrometry-based techniques for the detection of 
small organic compounds has arisen due to practical challenges associated with the use of 
mass spectrometry that limit broad-based applicability.1–3 Such challenges include the fact 
that expensive, bulky instrumentation is often required in order to accomplish mass 
spectrometry-based detection combined with significant user training to operate the 
instrumentation, which prevents detection by relatively untrained citizen scientists.4 Many 
newly developed chemosensors have focused on systems that allow for portable, on-site 
testing of the target analytes, without requiring high-end, costly laboratory 
instrumentation.5,6 A challenging aspect of designing portable chemosensors is the need to 
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maintain high selectivity, sensitivity, and broad-based applicability in the efficient 
detection of various analytes, especially among analytes that might be similar in structure 
and size.  
By utilizing the ability of cyclodextrin to act as a supramolecular scaffold that facilitates 
proximity-induced, highly analyte-specific interactions between an analyte of interest and 
a high quantum yield fluorophore, the Levine group has developed sensitive and selective 
fluorescence-based systems for toxicant detection.7–10 The systems utilize cyclodextrin-
promoted fluorescence energy transfer from a toxicant to a high quantum yield fluorophore, 
for photophysically-active analytes,11 or cyclodextrin-promoted, toxicant-specific 
fluorescence modulation, for non-photophysically active analytes.8 In addition to 
monitoring the analyte-specific fluorescence changes, there are often analyte-specific color 
changes in the fluorophore, promoted through the cyclodextrin-assisted interaction of the 
brightly colored fluorophore and the target analyte.12 Advantages of colorimetric detection 
include the fact that the color changes can be easily detected using naked eye detection13 
or RGB analysis.14 Significant literature precedent indicates that colorimetric analysis can 
be optimized for detection of very small concentrations of toxicants, both in solution-state 
as well as in solid-state detection devices.15–17 
Colorimetric detection has potential utility in the detection of aliphatic alcohols, a class of 
analytes commonly found in commercial products that, in high concentrations, can cause 
health concerns.18–20 These alcohols, including isopropanol, ethanol, and methanol, are 
found in household cleaners,21 paints,22 self-care and beauty products,23 as well as in 
beverages.24 Moreover, the need for detection of aliphatic alcohols is rising with the 
increasing prevalence of at-home beer and alcohol production.25 With almost no regulation 
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of this process currently in place, there is significant potential for poorly regulated ethanol 
concentrations26 as well as the potential for methanol contamination and associated 
methanol toxicity.27 Furthermore, the brewing process can sometimes lead to the formation 
of other byproducts including n-propanol, isobutanol, and isoamyl alcohol.28 Because 
methods to detect these byproducts are not widely available, significant public health risks 
from their ingestion remain.29 Additional potential applications of colorimetric aliphatic 
alcohol detection include the use of a colorimetric device to detect alcohol intoxication in 
both medical30 and law-enforcement settings.31,32 Finally, forensic post-mortem analysis 
would benefit from the detection of a range of aliphatic alcohols that are byproducts of 
certain bacteria and could provide important information as in a forensic investigation. 31,33  
While the fluorescence modulation method used previously in the Levine group provided 
good sensitivity and high selectivity among structurally similar analytes, it required 
laboratory-grade instrumentation, which severely limits widespread usage. Although 
portable fluorimetry has been accomplished using smartphone-based systems,15,34–38 these 
systems can be challenging for the user to implement, which means that portable 
colorimetric systems can have notable advantages. Reported herein is the development of 
an extremely practical colorimetric detection system for isopropanol, ethanol, and 
methanol, based on color changes in a dye-cyclodextrin complex upon addition of the 
aliphatic alcohol, with such color changes intimately dependent on the structure of each of 
the alcohols and its association with both the cyclodextrin scaffold and the colorimetric 
dye. This system is highly robust, with alcohol-induced color changes detectable even by 
a high school student) working with unpurified tap water solutions, and even in its 
optimized formulation uses no laboratory-grade instrumentation. Rather, the system uses a 
5 
 
spray-painted plastic box equipped with LED lights to facilitate consistent coloration and 
enable reproducible results.  
EXPERIMENTAL SECTION 
 
Figure 1: Structure of alcohol analytes (1-3) and highly colored dyes (4-5) 
Materials and Methods: The alcohol analytes 1-3 and dyes 4 and 5 shown in Figure 1 were 
obtained from Millipore-Sigma chemical company and the cyclodextrins were obtained 
from Tokyo Chemical Industry (TCI) chemical company. All chemicals were used as 
received. All aqueous solutions were made in glass jars and transferred to 50 mL white, 
polypropylene cups that had previously been used in a Keurig machine and were washed 
thoroughly prior to usage. A plastic container (with dimensions 21 cm x 15 cm x 7 cm) 
was painted using Krylon Fusion Satin Black spray paint to limit ambient light, and a 1.5 
cm x 1.5 cm hole was cut in the center of the lid to enable photography of the solution. An 
additional polypropylene cup previously used for a Keurig machine was positioned under 
the opening and secured to the bottom of the container with electrical tape. Two strips of 
LED white light tape (purchased from The Home Depot) were placed on the interior of the 
container, on all sides of the container, to provide uniform sample illumination. An 
annotated figure of the lightbox can be found in the Electronic Supporting Information. 
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The cup that contained sample was placed into the secured cup prior to imaging. Photos of 
the solutions were taken from 2.0 cm above the top of the sample cup with a Samsung 
Galaxy S8+ (model number: G950U) on manual mode with the following settings: ISO set 
to 100, aperture set to 1/350, macro focused (close-up focus), and the white balance set at 
5500K. These settings were kept constant for all trials to avoid variation in color capture. 
Images were processed with ImageJ software to measure the red, green and blue values 
(RGB) of the solutions, following the procedures detailed below. 
General procedure for making stock solutions: Three 250 mL solutions of β-cyclodextrin 
(β-CD), methyl-β-cyclodextrin (Me-β-CD), and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-
CD) cyclodextrin were made at relatively high concentrations (Table 1). The stock 
solutions for dyes 4 and 5 were made in isopropanol at concentrations of 3.80 mM and 2.08 
mM respectively (1 mg/mL for each dye). Diluted dye solutions were prepared by adding 
5.0 mL of the concentrated stock solutions to a 150 mL volumetric flask and diluting to the 
mark with water.  
Table 1: Concentration of cyclodextrins and dyes in solution.a 
Solute Solvent Concentration (mM) 
β-CD DI H2O 16.5 
Me-β-CD DI H2O 9.69 
2-HP-β-CD DI H2O 2.39 
Dye 4 Isopropanol 3.82 
Dye 5 Isopropanol 2.08 
a The final solution concentrations were calculated based on the amounts of solute and solvent 
added. See text for more information. 
General procedure for the optimization of supramolecular cyclodextrin host: In a glass 
sample jar, 10.00 mL of β-CD stock solution was combined with 10.00 mL of one of the 
diluted dye solutions. This mixture was manually shaken for one minute to ensure thorough 
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mixing. After mixing, 5.00 mL of alcohol was added. This mixture was transferred to the 
sample cup and placed in the lightbox. The cover was placed on and a photo was taken 
using the smartphone with the settings listed above. This procedure was repeated for Me-
β-CD and 2-HP-β-CD with both dyes and each of the three alcohols (18 total samples). 
Four trials of each sample were completed with a calculated average standard deviation in 
red, green and blue values of 0.08%, 0.14%, and 1.99% respectively. 
General procedure for the optimization of analyte concentration: Preparation of the 
cyclodextrin-dye solution was performed following the procedures detailed above, with 2-
HP-β-CD used as the host. A 0.5 M solution of the alcohol was made by adding alcohol to 
the cyclodextrin-dye solution in the glass jar, with additional samples tested for each 
alcohol at a variety of concentrations (0.5 M, 1.0 M, 2.0 M, and 3.0 M) using both dye 4 
and 5 (8 samples, 3 trials each). These solutions were transferred to a sample cup, placed 
in the lightbox, and a photo was taken of every sample. 
General procedure for calculating the limits of detection (LOD) and limits of quantification 
(LOQ): The limit of detection (LOD), defined as the lowest concentration of the analyte 
that can be detected, was obtained using the calibration curve method, following 
procedures reported by Loock and co-workers.39 The limit of detection of the blank 
(LODblank) is defined according to Equation 1, below: 
LODblank = mblank + 3(SDblank)    Eq. 1 
where m is the average of the values obtained from the blank sample and SD is the standard 
deviation of those measurements. The limit of quantification (LOQ), the lowest 
concentration of analyte that can be quantified.40 The limit of quantification of the blank is 
defined according to Equation 2, below: 
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LOQblank = mblank + 10(SDblank)    Eq. 2 
where m is the average of the values obtained from the blank sample and SD is the standard 
deviation of those measurements. 
The cyclodextrin-dye solution was prepared as mentioned above using only 2-HP-β-CD as 
a supramolecular host. This solution was transferred to the sample cup and placed in the 
spray-painted box. A photograph was taken in order to obtain the blank measurement of 
the solution, in the absence of any alcohol. Using a 20-200 μL Fisherbrand Elite 
micropipette, 100 μL of an alcohol was added and a picture was taken. These 100 μL 
additions continued until 6.0 mL of alcohol had been added to the solution. This process 
was repeated three times for each alcohol and in the presence of each dye. The RGB values 
of the solution were used to determine the level of detection of each alcohol in both dyes. 
General procedure for obtaining RGB values: Photos were cropped to be the same 
500x500 pixel ratio focused on the center of the sample (using https://www.birme.net) to 
ensure the area of the picture that was being measured was consistent across all samples. 
These images were processed using the RBG measurement tool plug-in that is available 
for the ImageJ software. Figures of these procedures can be found in the Electronic 
Supporting Information of this manuscript.  
General procedure for conducting linear discriminant analyses: SYSTAT 13 statistical 
computing software was used to quantify the degree of separation of color change in the 
solutions using the following settings for linear discriminant analysis (LDA): (a) Classical 
Discriminant Analysis; (b) Grouping Variable: Analytes (alcohols); (c) Predictors: Red, 
Green, Blue; (d) Long-Range Statistics: Mahal.7  
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General procedure for computational modeling:  Spartan ’18 was used to calculate the 
equilibrium values for the analytes in their ground-state electric potential surfaces using a 
semi-empirical PM3 model for each analyte. Molecular Operating Environment 2018 
(MOE) was used to do the docking studies for each dye, alcohol analyte, and 2-HP-β-CD 
host. A general energy minimization was performed using the “quick prep” function on the 
software. For the docking studies, the set of atoms defined as the receptor was both 2-HP-
β-CD and the solvent so that the dye could move freely in the system. Placement was done 
using the Triangle Matches method with London Dispersion dG score in 30 poses. 
Refinement was done using the Rigid Receptor method with GBVI/WSA dG score in 5 
poses. This generated the docking of the dye-cyclodextrin complex with the lowest energy 
confirmation. Summary figures generated from these procedures can be found in the 
Supporting information of this manuscript.  
RESULTS AND DISCUSSION 
Optimization of cyclodextrin 
A variety of cyclodextrin hosts were screened, with the goal of determining which 
supramolecular host would provide maximum separation between the analyte-induced 
color changes, with such separation quantified as the “cumulative proportion of total 
dispersion.” An example of significant dispersion of analyte clusters is shown for 2-HP-β-
CD (Figure 2C), and a contrasting example with overlapping areas between clusters is 
shown for Me-β-CD (Figure 2B). Using linear discriminant analysis of the RGB data 
collected from the sample photos, it was determined that the 2-HP-β-CD had the highest 
dispersion using both dye 4 and 5 as color-changing elements, with cumulative proportion 
of total dispersion values of 1.000 and 0.998 respectively (Table 2). Similar trends in the 
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cyclodextrin host were seen with dye 5 (Figure 3), with 2-HP- β-CD showing the greatest 
dispersion (Figure 3C) compared to of β-CD and Me-β-CD (Figure 3A and 3B, 
respectively).  
 
Figure 2. Generated arrays for the detections of ethanol, isopropanol, and methanol with 
each cyclodextrin supramolecular host using dye 4: (A) β-cyclodextrin; (B) Methyl-β-
cyclodextrin; and (C) 2-hydroxypropyl-β-cyclodextrin 
 
 
Figure 3. Generated arrays for the detections of ethanol, isopropanol, and methanol with 
each cyclodextrin supramolecular host using dye 5: (A) β-cyclodextrin; (B) Methyl-β-
cyclodextrin; and (C) 2-hydroxypropyl-β-cyclodextrin 
Table 2: Cumulative proportions of total dispersion for each                                     
cyclodextrin with dye 4 and 5.a 
Dye β-CD Me-β-CD 2-HP-β-CD 
4 0.915 0.986 1.000 
5 0.778 0.749 0.998 
a
 Values were generated after analysis using SYSTAT 13 
LDA software. 
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The higher signal dispersion that was observed when using 2-HP-β-CD is likely due to 
strong binding between the dyes and 2-HP-β-CD, as well as the high flexibility and water 
solubility of 2-HP-β-CD compared to the other hosts investigated.41 High binding constants 
between the alcohol analytes and cyclodextrin hosts increase the strength of interactions 
between the analyte, host and dye, resulting in more sensitive analyte-induced signal 
changes, whereas greater flexibility and water solubility increase the availability of this 
host to participate in the desired interactions. 42–44  
Further insight into the selectivity observed between the alcohol analytes was obtained 
from computational investigations. Electrostatic potential mapping of analytes 1-3, 
generated using Spartan ’18 software, showed significant similarities in the analyte 
structures, with areas of high polarity around the hydroxyl group (Figure 4). Differences 
between the analytes include noticeable size differences as well as a more concentrated 
region of positive electron density in analyte 1 compared to the other analytes, as shown 
by the dark blue color. Such differences contribute to differing binding affinities with the 
cyclodextrin, resulting in turn in high specificity in the analyte-induced color changes. 
 
Figure 4. Electrostatic potential maps of (A) analyte 1; (B) analyte 2; and (C) analyte 3. 
Red areas indicate regions of negative electron density and blue areas indicate regions of 
positive electron density. These computations were done using Spartan ‘18 software. 
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Determining the optimal concentrations for testing 
In order to determine the optimal analyte concentration to achieve high degrees of analyte-
induced separation in the colorimetric responses, the dependence of the LDA plots on 
analyte concentration was explicitly investigated, and the results are summarized in Table 
3. These results indicate that dye 4 was more effective in characterizing data at high analyte 
concentrations (3.0 M, Figure 5), whereas dye 5 provided more dispersed and accurate 
results between 0.5 M and 2.0 M concentrations (Figure 6). A plausible explanation for 
these observed results relates to the higher binding constant between dye 4 and 2-HP-β-
CD of 3.32x105 M-1 compared to 1.59 x 105 M-1 between dye 5 and the cyclodextrin. The 
lower binding constant of dye 5 allows for better detection at lower alcohol concentrations 
because the dye is being displaced easier. Because dye 4 binds with a slightly higher 
binding energy, a higher concentration of alcohol needs to be added to the system in order 
to displace the dye, causing an overall decrease in system performance. 
Table 3: Percent correct classification values obtained from                               
Jackknifed Classification analysis of the arrays.a 
Dye 0.5 M 1.0 M 2.0 M 3.0 M 
4 56 22 67 89 
5 67 100 100 78 
a Values taken after linear discriminant analysis was 
conducted using SYSTAT version 13 software. 
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Figure 5. Linear discriminant analysis results obtained at 3.0 M analyte concentration for: 
(A) dye 4 and (B) dye 5. All results were obtained using SYSTAT version 13 and following 
the procedures detailed in the experimental section. 
 
Figure 6. Linear discriminant analysis results generated at lower analyte concentrations. 
(A) Dye 4 at 0.5 M concentration analyte; (B) Dye 4 at 1.0 M concentration analyte; (C) 
Dye 4 at 2.0 M concentration analyte; (D) Dye 5 at 0.5 M concentration analyte; (E) Dye 
5 at 1.0 M concentration analyte; and (F) Dye 5 at 2.0 M concentration analyte. All results 
were obtained using Systat version 13 and following the procedures detailed in the 
experimental section. 
Additional computational studies conducted using MOE 2018 software provided important 
information about the lowest energy docking conformation of each dye with 2-HP-β-CD, 
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and results are shown in Figure 7. Of note, BODIPY (4) exhibited markedly more inclusion 
in the cyclodextrin host compared to Rhodamine (5), with a substantial portion of the dye 
remaining exposed to the solvent. This solvent-exposed area of Rhodamine has a greater 
ability to interact with the analyte in solution, resulting in more responsiveness at lower 
analyte concentrations compared to BODIPY. 
This result implies that dye displacement by the alcohol may not be necessary to affect a 
color change if the alcohol and dye interact via the solvent-accessible portion. Such 
interactions are not dependent on the binding constant of the dyes in cyclodextrin and 
provide an additional mechanism by which the system can lead to analyte-specific color 
changes. Efforts to investigate the extent to which either or both mechanisms (i.e., dye 
displacement from the cavity and/or interactions between the dye and analyte through 
solvent exposed areas) are operative in this system are currently underway in our 
laboratory. 
Moreover, the addition of the alcohol analyte to the solution of dye in cyclodextrin had 
measurable changes on the supramolecular complex. In particular, computational results 
indicated that adding methanol to a solution of BODIPY in 2-HP-β-CD resulted in the 
weakening of the association between BODIPY and 2-HP-β-CD and strengthening of the 
affinity of the BODIPY for the solvent (Figure 8). This result supports that colorimetric 
changes induced by the addition of the alcohol analyte are a result of decreased affinity of 
the dye for the hydrophobic cyclodextrin cavity. 
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Figure 7: Lowest energy conformations of BODIPY (4) and Rhodamine (5) in 2-HP-β-
CD. (A) Side view of the complex with BODIPY (4). (B) Aerial view of the complex with 
BODIPY (4). (C) Side view of the complex with Rhodamine (5). (D) Aerial view of the 
complex with Rhodamine (5). Color coding: for the cyclodextrin host, the dark blue color 
represents the carbon atoms, the red color represents the oxygen atoms, and the gray color 
represents hydrogen atoms. For BODIPY, the purple color represents carbon atoms, gray 
represents hydrogen, blue represents nitrogen, orange represents boron, and green 
represents fluorine. For Rhodamine, the teal color represents carbon, gray represents 
hydrogen, red represents oxygen, and dark blue represents nitrogen. 
 
 
 
 
16 
 
 
Figure 8: Lowest energy conformations of BODIPY (4) in 2-HP-β-CD following the 
introduction of methanol. The methanol is modeled as teal stick figures, and the colors of 
the BODIPY and cyclodextrin are identical to the colors used in Figure 7. 
Determining the LOD and LOQ for the analytes with dyes 4 and 5 
In addition to measuring the ability of the system to differentiate between structurally 
similar analytes, the sensitivity of the system to low analyte concentrations was also 
investigated. These results are summarized in Table 4 (for 0.127mM BODIPY and 
0.093mM Rhodamine) and Table 5 (for 0.382mM BODIPY and 0.280mM Rhodamine), 
and indicate that analyte concentrations as low as 0.2 M were detectable via this method 
(for isopropanol using relatively high concentrations of Rhodamine). Compared to the 
LODs reported in Table 3, there was no significant decrease in the LODs observed with 
BODIPY. In contrast, the Rhodamine trial showed much better improvement at higher dye 
concentrations with a 48% decrease in the LOD and a decrease of 68% in the LOQ value. 
These marked changes are in line with the higher solvent and analyte accessibility 
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displayed by Rhodamine (vide supra), and indicate substantial promise in the further 
optimization of sensitive alcohol sensors. An example of a color array that illustrates the 
visible color change of BODIPY in the presence of isopropanol is shown in Figure 9.   
Table 5: LODs and LOQs of each alcohol with dyes 4 and 5 in the                        
presence of 2-HP-β-CD. 
Dye Alcohol LOD (M)a LOQ (M)b 
4 
Isopropanol 0.319 0.805 
Ethanol 0.491 1.74 
Methanol 0.249 0.823 
5 
Isopropanol 0.386 1.05 
Ethanol 0.216 0.442 
Methanol 0.331 0.730 
a 
Values calculated according to Equation 1 and the equation of the line of best fit for each dye-
alcohol complex. 
b Values calculated according to Equation 2 and the equation of the line of best fit for each dye-
alcohol complex. 
Table 6: LODs and LOQs of isopropanol with increased concentrations of                   
dye 4 and 5 and 2-HP-β-CD. 
Dye LOD (M) LOQ (M) 
4 0.3170 (0.50%) a 0.7812 (3.0%) 
5 0.2004 (48%) 0.3341(68%) 
a 
Number in parentheses represents the percent change, in all cases a 
decrease, from the LOD values obtained in Table 4 to the ones calculated 
using a higher concentration of dye in solution. 
 
Figure 9. Colorimetric array of the 60 samples from the trial using dye 4 and analyte 3. 
The concentration of analyte increases from left to right. 
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CONCLUSIONS 
Harnessing the highly specific complexation of small molecules guests inside 
supramolecular cyclodextrin hosts provides a fundamentally unique system for the 
detection of those guests. Reported herein is the application of such host-guest complexes 
for the colorimetric detection of alcohol, using highly practical, easily available materials 
to achieve excellent selectivity (100% differentiation) and moderate sensitivity (as low as 
0.2 M). Computational experiments involving the cyclodextrin, analytes, and highly 
colored dyes are invoked to explain the underlying basis of this strong analyte specificity, 
as remarkably structurally similar analytes leading to noticeably different colorimetric 
read-out signals. Efforts to improve the sensitivity and broaden the scope of such detection 
are currently underway in our laboratory, and results of these and other investigations will 
be reported in due course.  
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MATERIALS AND METHODS 
The alcohol analytes and dyes were obtained from Millipore Sigma chemical company and 
the cyclodextrins were obtained from Tokyo Chemical Industry chemical company, and all 
chemicals were used as received. Samples were illuminated using the homemade lightbox 
detailed on the following page. All photos were taken with a Samsung Galaxy S8+ (model 
number: G950U) on manual mode with the following settings: ISO set to 100, aperture set 
to 1/350, macro focused (close-up focus), and the white balance set at 5500K. Images were 
cropped using software from https://www.birme.net. Fluorescence measurements for the 
binding experiments were performed using a Shimadzu RF 6000 spectrophotometer. Both 
the excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were 
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays 
were generated using SYSTAT Version 13.1.  
DETAILS OF ANALYTES AND DYES 
 
Figure 10: Structure of alcohol analytes and highly colored dyes 
All analytes were used as received. The dyes were prepared at a concentration of 1.0 
mg/mL in isopropanol. Diluted dye solutions were prepared by diluting 5.0 mL of the 
concentrated stock solutions with 150 mL of DI H2O, based on the dilution factor used by 
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high school student Priva Halpert. The final concentrations of the dyes are shown in the 
table below. 
Table 7. Concentration of Dyes in Solution   
 
Dye Number 
Concentration before 
Dilution (mM) 
Final Concentration 
(mM) 
4 3.796 0.1265 
5 2.079 0.0693 
 
EXPERIMENTAL DETAILS FOR CYCLODEXTRIN SOLUTIONS 
The method for making the cyclodextrin solutions was taken from the previous work of 
high school student Priva Halpert working under the supervision of Dr. Levine. As a high 
school student working remotely, Halpert based her measurements on volume of each 
component, using teaspoons, cups, etc. In her procedure, 0.5 teaspoon of cyclodextrin 
was added to 0.25 cups (59.15 mL). We wanted to replicate her procedure and converted 
her measurement of 0.5 teaspoons to grams for each cyclodextrin and scaled up to make a 
solution with a final volume of 250 mL. These conversions are summarized in the table 
below, together with the final concentrations of the cyclodextrins. 
Table 8. Volume to Mass Conversions of Cyclodextrins and Final Concentrations 
Cyclodextrin 
Mass of 0.5 
teaspoons (g) 
Mass added to 250 
mL of DI H2O (g) 
Final 
Concentration 
(mM) 
β-Cyclodextrin 1.470 4.6806 16.49 
Methyl-β-
Cyclodextrin 
0.750 3.1717 9.685 
2-hydroxypropyl-
β-CD 
0.778 3.2852 2.389 
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EXPERIMENTAL DETAILS FOR CONSTRUCTION OF THE LIGHTBOX 
A plastic container (with dimensions 21 cm x 15 cm x 7 cm) was painted using Krylon 
Fusion Satin Black spray paint to limit ambient light, and a 1.5 cm x 1.5 cm hole was cut 
in the center of the lid to enable photography of the solution. An additional polypropylene 
cup previously used for a Keurig machine was positioned under the opening after 
thoroughly washing, and secured to the bottom of the container with electrical tape. Two 
strips of LED white light tape (purchased from The Home Depot) were placed on the 
interior of the container, on all sides, and turned on to provide uniform sample illumination.  
       
Figure 11. Annotated dimensions of lightbox      Figure 12. Annotated top-view of lightbox 
       
Figure 13. Illuminated lightbox                           Figure 14. Illuminated lightbox 
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EXPERIMENTAL DETAILS FOR CROPPING PHOTOGRAPHS AND RGB 
MEASUREMENTS 
All photographs were cropped using the online tool found at https://www.birme.net. 
Photos from the same trial were uploaded to the site then cropped to a 500x500 pixel 
ratio (Figure 15). The cropped photos were then opened into the ImageJ software. These 
measurements were recorded using the RGB measurement plug-in provided in the 
software (Figure 16). 
 
Figure 15. Cropping sample photos to 500x500 pixel ratio using software on 
https://www.birme.net 
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Figure 16. Processing of cropped sample photo using the ImageJ software RGB 
Measurement plug-in. 
 
EXPERIMENTAL DETAILS FOR THE OPTIMIZATION OF THE 
SUPRAMOLECULAR CYCLODEXTRIN HOST  
In a glass sample jar, 10.0 mL of β-cyclodextrin stock solution was combined with 10.0 
mL of one of the diluted dye solutions. This mixture was manually shaken for 1 minute to 
ensure a homogeneous mixture. After mixing, 5.0 mL of alcohol was added. This mixture 
was transferred to the sample cup and placed in the lightbox. The cover was placed on 
and a photo was taken using the smartphone with the settings detailed above. This 
procedure was repeated for methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin 
with both dyes and each of the three alcohols (18 total samples). These samples were 
replicated 4 times in total with an average standard deviation in RGB values of 0.70%. 
Full summary tables of standard deviation and standard deviation percentages can be seen 
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on page S15. As a control, experiments were also conducted in the absence of 
cyclodextrin but under otherwise identical conditions. Summary tables and figures from 
these experiments are included herein.  
EXPERIMENTAL DETAILS FOR THE OPTIMIZATION OF ANALYTE 
CONCENTRATION 
In a glass sample jar, 10.0 mL of 2-hydroxypropyl-β-cyclodextrin stock solution was 
combined with 10.0 mL of one of the diluted dye solutions. This mixture was manually 
shaken for 1 minute to ensure a homogeneous mixture. A 0.5 M solution of the alcohol was 
made by adding the corresponding amount of alcohol to the cyclodextrin-dye solution in 
the glass jar, with additional samples tested for each alcohol at a variety of concentrations 
(0.5 M, 1.0 M, 2.0 M, and 3.0 M) using both BODIPY and Rhodamine dyes (8 samples 
replicated 3 times each). The volume of alcohol necessary to obtain an 0.5 M solution is 
seen in the table below. These solutions were transferred to a sample cup, placed in the 
lightbox, and a photo was taken of each. 
Table 9. Amount of Alcohol Added in Each Solution 
Cyclodextrin 0.5 M 1.0 M 2.0 M 3.0 M 
Isopropanol 0.790 mL 1.650 mL 3.590 mL 5.915 mL 
Ethanol 0.600 mL 1.240 mL 2.640 mL 4.240 mL 
Methanol 0.415 mL 0.845 mL 1.765 mL 2.770 mL 
 
EXPERIMENTAL DETAILS FOR LIMIT OF DETECTION EXPERIMENTS 
The limit of detection (LOD), defined as the lowest concentration of the analyte that can 
be detected, was obtained using the calibration curve method, following procedures 
reported by Loock et. al. The limit of quantification (LOQ) is the lowest concentration of 
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analyte that can be quantified. The limit of detection1 and quantification2 experiments were 
conducted following literature-reported procedures. 
To determine the LOD and LOQ, each dye-analyte combination in 2-hydroxypropyl-β-
cyclodextrin solution was examined in the following manner: 
1. In a glass sample jar, 10.0 mL of 2-hydroxypropyl-β-cyclodextrin stock solution was 
combined with 10.0 mL of one of the diluted dye solutions. This mixture was manually 
shaken for 1 minute to ensure a homogeneous mixture. 
2. The solution was transferred to a sample cup and subsequently placed in the light box. 
A photo was taken in order to obtain the blank measurement of the solution (i.e. in the 
absence of any alcohol, before any analyte had been added). 
3. Using a 20-200 μL Fisherbrand Elite micropipette, 100 μL of an alcohol was added and 
a picture was taken. These 100 μL additions continued until 6.0 mL of alcohol was in 
solution. 
4. Steps 1-3 were repeated 3 times for each dye-analyte combination (6 combinations, 18 
total samples). 
5. Photos were cropped to a 500x500 pixel ratio centered on the center of the sample cup 
using software from https://www.birme.net and the RGB values of the photos were 
measured using the RGB measurement plug-in tool in the ImageJ software. 
6. The Green values (Y-axis) were chosen to be plotted verses the molarity (X-axis), 
because they exhibited the most consistent trends. Calibration curves were generated, fitted 
with an exponential function and an equation was determined. 
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7. The limit of the blank is defined according to the following equation: 
𝐿𝑂𝐷𝐵𝑙𝑎𝑛𝑘 = 𝑚𝐵𝑙𝑎𝑛𝑘 + 3(𝑆𝐷𝐵𝑙𝑎𝑛𝑘), 
where m is the average of the values obtained from the blank sample and SD is the standard 
deviation of those measurements. 
8. The limit of the blank was entered as the y-value in the equation from step 6, and the 
corresponding x-value was calculated. This value was the LOD of the system in M. 
9. The LOQ was determined in a similar procedure to the LOD. The limit of quantification 
blank is defined according to the following equation:  
𝐿𝑂𝑄𝐵𝑙𝑎𝑛𝑘 = 𝑚𝐵𝑙𝑎𝑛𝑘 + 10(𝑆𝐷𝐵𝑙𝑎𝑛𝑘). 
This value is then inputted as the y-value in the equation from step 6, and the corresponding 
x-value was calculated. This value is the LOQ for the system in M.  
EXPERIMENTAL DETAILS FOR BINDING CONSTANT EXPERIMENTS 
Fluorescence measurements were performed on a Shimadzu RF 6000 spectrophotometer. 
Both the excitation and emission slit widths were set to 3.0 nm.  
A 1.45 mM solution of 2-HP-β-CD was prepared in DI H2O. A solution of 2.09 mM Dye 
5 was prepared in DI H2O and a 2.54 mM solution of Dye 4 was prepared in 
tetrahydrofuran, with the solvent selection and concentration optimized based on 
concentration. In both binding experiments, 2.50 mL of water was added to quartz cuvette. 
In the Dye 5 trial, 8 μL of the dye was added. In the Dye 4 series, 10.5 μL was added. The 
tip of the micropipette was used to stir the solution in the cuvette to ensure a homogeneous 
mixture. Fluorescence measurements of these were taken 4 times. In each trial, 1 μL of the 
Equation 1. 
Equation 2. 
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2-HP-β-CD solution was added to the cuvette and the same scanning process was 
completed. This was repeated for the total addition amounts seen on page S19 in Tables 
S10 and S11, the total addition amount representing the concentration at which the 
observed signal plateaued. All fluorescence spectra were integrated vs. wavenumber on the 
X-axis using OriginPro 2019 Version 9.60. Binding constants (Ka) were determined using 
the equation shown below: 
𝐹/𝐹0  =  1 +  ((𝐹/𝐹0)𝑚𝑎𝑥 − 1)(𝐾𝑎[𝐺]0/(1 + 𝐾𝑎[𝐺]0), 
where F is the fluorescence of the sample, F0 is the fluorescence of the blank, [G] is the 
concentration of the guest which in this case is 2-HP-β-CD, and Ka is the binding constant. 
The average Ka was determined to be 3.32 x 10
5 M-1 and 1.59 x 105 M-1 for Dye 4 and 5 
respectively. 
EXPERIMENTAL DETAILS FOR ARRAY GENERATION EXPERIMENTS 
Array analysis was performed using SYSTAT 13 statistical computing software with the 
following settings: 
(a) Classical Discriminant Analysis 
(b) Grouping Variable: Analytes 
(c) Predictors: Red, Green, Blue 
(d) Long-Range Statistics: Mahal 
Arrays were generated for all analyte-dye-cyclodextrin combinations in the optimization 
experiments.  
 
 
Equation 3. 
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EXPERIMENTAL DETAILS FOR COMPUTTIONAL MODELING 
Spartan ’18 was used to calculate the equilibrium at ground state in gas using a semi-
empirical PM3 model for each analyte (Figure 8).  This allowed an electrostatic potential 
map surface to be overlaid on the molecules. Molecular Operating Environment 2018 
(MOE) was used to do the docking studies for each dye and 2-HP-β-CD. A general energy 
minimization was performed using the “quick prep” function and the default settings. For 
the docking studies, the set of atoms defined as the receptor was both 2-HP-β-CD and the 
solvent so that the dye could move freely in the system. Placement was done using the 
Triangle Matches method with London Dispersion dG score in 30 poses. Refinement was 
done using the Rigid Receptor method with GBVI/WSA dG score in 5 poses (Figure 9). 
This generated the docking of the dye-cyclodextrin complex with the lowest energy 
confirmation. 
 
Figure 17. Spartan dialogue box with the settings used for calculation of equilibrium 
geometry. 
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Figure 18. MOE 2018 dialogue box with the settings used for the docking calculations. 
 
SUMMARY TABLES FOR OPTIMIZATION OF CYCLODEXTRIN 
EXPERIEMNTS 
Table 10. RGB Measures of Cyclodextrin-Analyte Combinations with Dyes 4 and 5 
  Dye 4 Dye 5 
Cyclodextrin Analyte Red Green Blue Red Green Blue 
β-CD 
Isopropanol 
229.326 162.309 2.674 248.446 125.19 1.782 
229.686 162.166 2.711 248.196 125.264 1.796 
229.522 162.683 2.708 248.35 125.206 1.791 
229.631 161.993 2.696 248.282 125.225 1.792 
Ethanol 
228.556 164.062 3.058 245.065 125.688 1.8 
228.86 163.756 3.086 244.803 125.694 1.851 
228.839 164.402 2.95 244.971 125.699 1.808 
228.928 163.684 2.902 244.848 125.665 1.834 
Methanol 
228.012 162.721 2.156 246.063 126.866 1.569 
228.335 162.413 2.136 245.885 126.996 1.788 
228.145 162.91 2.119 246.043 126.965 1.625 
228.218 162.214 2.182 245.953 126.986 1.729 
M-β-CD Isopropanol 
229.38 159.869 2.965 248.249 125.159 3.753 
229.672 159.58 2.986 248.513 124.875 3.746 
229.307 159.911 2.972 248.176 125.165 3.736 
229.49 159.772 2.983 248.353 124.985 3.717 
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Ethanol 
229.054 159.4 2.789 247.118 124.484 4.095 
229.35 159.669 2.846 247.392 123.999 4.05 
229.012 158.958 2.826 247.011 124.875 4.086 
229.109 159.563 2.771 247.155 124.981 4.09 
Methanol 
229.02 159.398 2.81 248.061 124.455 3.459 
229.946 159.065 2.559 248.378 124.153 3.405 
228.449 159.348 2.787 247.963 124.484 3.614 
229.372 159.128 3.001 248.14 124.334 3.573 
2-HP-β-CD 
Isopropanol 
236.315 185.085 4.147 258.453 165.344 2.221 
236.88 185.564 4.111 257.953 164.814 2.176 
236.55 185.294 4.103 258.259 165.094 2.182 
236.641 185.368 4.129 258.174 165.003 2.184 
Ethanol 
233.448 158.496 3.736 259.583 167.58 2.677 
233.62 158.678 3.735 259.392 167.38 2.599 
233.931 158.977 3.676 259.093 167.151 2.604 
234.134 159.18 3.704 258.895 167.015 2.654 
Methanol 
238.767 155.928 3.401 257.994 160.909 2.843 
238.893 156.037 3.379 257.877 160.841 2.961 
238.56 155.729 3.384 258.159 161.11 2.372 
238.496 155.653 3.365 258.098 161.219 3.22 
 
Table 11. Standard Deviations of RGB Measures of All Cyclodextrin-Analyte 
Combinations with Dyes 4 and 5 
  Dye 4 Dye 5 
Cyclodextrin Analyte Red Green Blue Red Green Blue 
β-CD 
Isopropanol 0.1589 0.2935 0.0168 0.1058 0.0319 0.0059 
Ethanol 0.1643 0.3279 0.0873 0.1190 0.0150 0.0235 
Methanol 0.1353 0.3107 0.0271 0.0826 0.0596 0.0990 
Me-β-CD 
Isopropanol 0.1588 0.1473 0.0097 0.1462 0.1413 0.0156 
Ethanol 0.1511 0.3132 0.0341 0.1607 0.4452 0.0205 
Methanol 0.6278 0.1630 0.1810 0.1771 0.1504 0.0973 
2-HP-β-CD 
Isopropanol 0.2336 0.1979 0.0196 0.2072 0.2202 0.0205 
Ethanol 0.3076 0.3048 0.0287 0.3063 0.2496 0.0382 
Methanol 0.1837 0.1768 0.0149 0.1238 0.1752 0.2407 
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Table 12. Percent Standard Deviations of RGB Measures of Cyclodextrin-Analyte 
Combinations with Dyes 4 and 5 
  Dye 4 Dye 5 
Cyclodextrin Analyte Red Green Blue Red Green Blue 
β-CD 
Isopropanol 0.069% 0.181% 0.623% 0.043% 0.025% 0.330% 
Ethanol 0.072% 0.200% 2.911% 0.049% 0.012% 1.290% 
Methanol 0.059% 0.191% 1.262% 0.034% 0.047% 5.900% 
Me-β-CD 
Isopropanol 0.069% 0.092% 0.327% 0.059% 0.113% 0.418% 
Ethanol 0.066% 0.196% 1.216% 0.065% 0.357% 0.502% 
Methanol 0.274% 0.102% 6.489% 0.071% 0.121% 2.769% 
2-HP-β-CD 
Isopropanol 0.099% 0.107% 0.476% 0.080% 0.133% 0.934% 
Ethanol 0.132% 0.192% 0.772% 0.118% 0.149% 1.450% 
Methanol 0.077% 0.113% 0.439% 0.048% 0.109% 7.766% 
 
SUMMARY TABLES FOR CONCETRATION OPTIMIZATION EXPERIEMNTS 
Table 13. RGB Measures of Varying Concentrations of Analyte in 2-HP-β-CD Solution 
with Dyes 4 and 5 
  Dye 4 Dye 5 
Analyte Concentration Red Green Blue Red Green Blue 
Isopropanol 
0.5 (M) 
238.111 147.305 2.193 254.733 156.79 1.866 
238.416 146.03 2.177 254.733 156.705 1.839 
238.381 145.778 2.097 254.706 156.172 1.781 
1.0 (M) 
238.845 150.321 2.277 254.754 159.842 2.522 
239.22 148.409 2.258 254.769 159.741 2.529 
239.194 148.797 2.261 254.773 158.386 2.243 
2.0 (M) 
238.872 164.365 2.656 254.667 164.322 2.479 
240.322 159.668 2.625 254.666 164.221 2.542 
239.51 156.642 2.554 254.683 163.836 2.64 
3.0 (M) 
235.774 184.183 3.744 254.65 164.844 2.401 
237.338 187.3 3.54 254.662 164.798 2.418 
236.972 181.636 3.29 254.65 164.483 2.443 
Ethanol 
0.5 (M) 
238.143 146.809 2.198 254.725 156.132 1.76 
237.959 146.661 2.206 254.735 156.577 1.885 
238.281 148.452 2.257 254.682 154.636 1.694 
1.0 (M) 
238.783 148.084 2.215 254.752 157.888 2.139 
238.571 147.951 2.262 254.762 158.104 2.21 
239.398 150.663 2.331 254.738 157.438 2.098 
2.0 (M) 
239.414 152.039 2.434 254.718 161.873 2.658 
238.579 150.438 2.327 254.7 162.154 2.702 
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239.706 153.549 2.493 254.714 162.028 2.555 
3.0 (M) 
239.551 157.139 2.594 254.656 164.283 2.502 
238.263 157.975 2.623 254.667 164.842 2.409 
239.108 159.737 2.593 254.693 164.471 2.493 
Methanol 
0.5 (M) 
238.6 148.121 2.255 254.625 154.415 1.642 
240.228 149.071 2.255 254.662 154.439 1.688 
240.219 148.381 2.263 254.666 154.457 1.713 
1.0 (M) 
238.891 149.142 2.281 254.727 156.382 1.829 
240.041 148.84 2.236 254.7 155.996 1.801 
240.045 148.386 2.246 254.704 155.403 1.85 
2.0 (M) 
239.694 152.425 2.403 254.751 159.123 2.361 
240.747 151.426 2.355 254.753 158.592 2.332 
240.915 150.847 2.356 254.758 158.342 2.218 
3.0 (M) 
239.049 154.9 2.53 254.711 161.973 2.679 
240.847 154.191 2.51 254.726 161.574 2.642 
241.502 153.745 2.5 254.708 162.272 2.586 
 
Table 14. Standard Deviations of RGB Measures of Varying Concentrations of Analyte 
in 2-HP-β-CD Solution with Dyes 4 and 5 
  Dye 4 Dye 5 
Analyte 
Concentratio
n 
Red Green Blue Red Green Blue 
Isopropano
l 
0.5 (M) 0.1669 0.8186 0.0514 0.0156 0.3350 0.0434 
1.0 (M) 0.2094 1.0107 0.0102 0.0100 0.8130 0.0047 
2.0 (M) 0.7267 3.8915 0.0523 0.0095 0.2565 0.0811 
3.0 (M) 0.8181 2.8368 0.2274 0.0069 0.1965 0.0211 
Ethanol 
0.5 (M) 0.1615 0.9941 0.0320 0.0282 1.0168 0.0970 
1.0 (M) 0.4296 1.5288 0.0583 0.0121 0.3398 0.0567 
2.0 (M) 0.5849 1.5557 0.0841 0.0095 0.1407 0.0754 
3.0 (M) 0.6544 1.3262 0.0170 0.0190 0.2844 0.0513 
Methanol 
0.5 (M) 0.9373 0.4910 0.0046 0.0226 0.0211 0.0360 
1.0 (M) 0.6651 0.3805 0.0236 0.0146 0.4931 0.0246 
2.0 (M) 0.6618 0.7983 0.0274 0.0036 0.3988 0.0756 
3.0 (M) 1.2701 0.5825 0.0153 0.0096 0.3502 0.0468 
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Table 15. Percent Standard Deviations of RGB Measures of Varying Concentrations of 
Analyte in 2-HP-β-CD with Dyes 4 and 5 
  Dye 4 Dye 5 
Analyte Concentration Red Green Blue Red Green Blue 
Isopropanol 
0.5 (M) 0.070% 0.559% 2.386% 0.006% 0.214% 2.375% 
1.0 (M) 0.088% 0.678% 0.451% 0.004% 0.510% 0.187% 
2.0 (M) 0.303% 2.429% 2.002% 0.004% 0.156% 3.177% 
3.0 (M) 0.346% 1.539% 6.451% 0.003% 0.119% 0.873% 
Ethanol 
0.5 (M) 0.068% 0.675% 1.441% 0.011% 0.653% 5.451% 
1.0 (M) 0.180% 1.027% 2.571% 0.005% 0.215% 2.637% 
2.0 (M) 0.244% 1.023% 3.480% 0.004% 0.087% 2.860% 
3.0 (M) 0.274% 0.838% 0.655% 0.007% 0.173% 2.078% 
Methanol 
0.5 (M) 0.391% 0.331% 0.205% 0.009% 0.014% 2.142% 
1.0 (M) 0.278% 0.256% 1.048% 0.006% 0.316% 1.346% 
2.0 (M) 0.275% 0.527% 1.157% 0.001% 0.251% 3.281% 
3.0 (M) 0.528% 0.378% 0.608% 0.004% 0.216% 1.776% 
 
SUMMARY TABLES OF LOD AND LOQ EXPERIMENTS 
Table 16. Table of LODs and LOQs of Each Alcohol with Dyes 4 and 5 in the Presence 
of 2-HP-β-CD 
Dye Analyte LOD (M) LOQ (M) Equation R2 
Dye 4 
Isopropano
l 
0.3187 0.8053 y = 3.304ex/1.163 + 141.606 0.9994 
Ethanol 0.4911 1.7387 y = 1.531ex/1.351 + 145.250 0.9973 
Methanol 0.2492 0.8235 y = 8.048ex/4.913 + 139.175 0.9986 
Dye 5 
Isopropano
l 
0.3856 1.0539 y = -14.641ex/-1.665 + 167.917 0.9799 
Ethanol 0.2163 0.4416 y = -21.511ex/-4.405 + 175.206 0.9935 
Methanol 0.331 0.7304 y = -26.284ex/-7.820 + 179.275 0.9964 
 
SUMMARY TABLES FOR BINDING EXPERIMENTS  
Total addition amounts of 2-HP-β-CD added into the cuvette with the dye solution. 
Additions were stopped when the fluorescence measurements begin to plateau. Full 
experimental details can be seen on page S11. 
 
39 
 
Table 17. Additions and Concentrations 
for Binding of Dye 4 in 2-HP-β-CD 
Volume 
of 2-
HP-β-
CD 
added 
(μL) 
[2-HP-β-
CD] (μM) 
[Dye 4] 
(μM) 
0 0.0000 6.383 
1 0.5790 6.380 
2 1.158 6.378 
3 1.736 6.375 
4 2.313 6.373 
5 2.890 6.370 
6 3.467 6.368 
7 4.043 6.365 
8 4.619 6.362 
12 6.918 6.352 
16 9.209 6.342 
20 11.49 6.332 
24 13.77 6.322 
28 16.04 6.312 
 
 
 
Table 18. Additions and Concentrations 
for Binding of Dye 5 in 2-HP-β-CD 
 
SUMMARY TABLES OF COLORIMETRIC ARRAY EXPERIMENTS 
Summary Tables of Cyclodextrin-Analyte Combinations with Dyes 4 and 5 Arrays 
Table 19. Analytes with β-CD and Dye 4 
 
 
 
Table 20. Analytes with Me-β-CD and Dye 4 
 
 
 
Volume 
of 2-
HP-β-
CD 
added 
(μL) 
[2-HP-β-
CD] (μM) 
[Dye 5] 
(μM) 
0 0.0000 6.659 
1 0.5790 6.656 
2 1.158 6.654 
3 1.736 6.651 
4 2.313 6.648 
5 2.890 6.646 
6 3.467 6.643 
7 4.043 6.640 
8 4.619 6.638 
12 6.918 6.627 
16 9.209 6.617 
20 11.49 6.606 
24 13.77 6.596 
28 16.04 6.585 
32 18.32 6.575 
36 20.58 6.565 
40 22.83 6.554 
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Table 21. Analytes with 2-HP-β-CD and Dye 4 
 
Table 22. Analytes with β-CD and Dye 5 
 
 
Table 23. Analytes with Me-β-CD and Dye 5 
 
Table 24. Analytes with 2-HP-β-CD and Dye 5 
 
 
Summary Tables for RGB Measures of Varying Concentrations of Analyte in 2-
Hydroxypropyl-β-Cyclodextrin Solution with Dyes 4 and 5 Arrays
Table 25. 0.5 M Analyte solution in 2-
HP-β-CD with Dye 4 
 
Table 26. 1.0 M Analyte solution in 2-
HP-β-CD with Dye 4 
 
Table 27. 2.0 M Analyte solution in 2-
HP-β-CD with Dye 4 
  
Table 28. 3.0 M Analyte solution in 2-
HP-β-CD with Dye 4 
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Table 29. 0.5 M Analyte solution in 2-
HP-β-CD with Dye 5 
 
Table 30. 1.0 M Analyte solution in 2-
HP-β-CD with Dye 5 
  
Table 31. 2.0 M Analyte solution in 2-
HP-β-CD with Dye 5 
  
Table 32. 3.0 M Analyte solution in 2-
HP-β-CD with Dye 5 
  
 
SUMMARY TABLES FOR CONTROL EXPERIMENTS 
Table 33. Analytes with Dye 4 in the absence of cyclodextrin 
  
Table 34. Analytes with Dye 5 in the absence of cyclodextrin 
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SUMMARY FIGURES COLORIMETRIC ARRAY EXPERIMENTS 
 
Figure 19. Analytes with β-CD and Dye 4 
 
Figure 20. Analytes with Me-β-CD and Dye 4 
 
Figure 21. Analytes with 2-HP-β-CD and Dye 4 
 
Figure 22. Analytes with β-CD and Dye 5 
 
Figure 23. Analytes with Me-β-CD and Dye 5 
 
Figure 24. Analytes with 2-HP-β-CD and Dye 5 
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Figure 25. 0.5 M Analytes in 2-HP-β-CD with Dye 4 
 
Figure 26. 1.0 M Analytes in 2-HP-β-CD with Dye 4 
 
Figure 27. 2.0 M Analytes in 2-HP-β-CD with Dye 4 
 
Figure 28. 3.0 M Analytes in 2-HP-β-CD with Dye 4 
 
Figure 29. 0.5 M Analytes in 2-HP-β-CD with Dye 5 
 
Figure 30. 1.0 M Analytes in 2-HP-β-CD with Dye 5 
 
Figure 31. 2.0 M Analytes in 2-HP-β-CD with Dye 5 
 
Figure 32. 3.0 M Analytes in 2-HP-β-CD with Dye 5 
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SUMMARY FIGURES FOR CONTROL EXPERIMENTS 
 
Figure 33. Analytes with Dye 4 in the absence of cyclodextrin 
 
Figure 34. Analytes with Dye 5 in the absence of cyclodextrin 
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SUMMARY FIGURES FOR ALL LOD EXPERIMENTS 
Red lines on each graph are representative of the lines of best fit of the equations given 
on page S18 in Table S9. 
 
Figure 35. Analyte 1 – Dye 4 
 
Figure 36. Analyte 2 – Dye 4 
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Figure 37. Analyte 3 – Dye 4 
 
Figure 38. Analyte 1 – Dye 5 
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Figure 39. Analyte 2 – Dye 5 
 
Figure 40. Analyte 3 – Dye 5 
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ABSTRACT 
The detection of anabolic steroids, particularly those that are commonly used in illegal 
doping scandals, remains a high priority research objective with applications in public 
health, law enforcement, and a variety of sporting disciplines. Reported herein are our 
efforts to address this objective, through the use of cyclodextrin-promoted interactions 
between the analyte of interest and a high quantum yield fluorophore, which lead to 
measurable, analyte-specific changes in the fluorophore emission signal. By using a variety 
of β-cyclodextrin derivatives (unmodified β-cyclodextrin, methyl-β-cyclodextrin, and 2-
hydroxypropyl-β-cyclodextrin) in combination with high quantum yield Rhodamine 6G as 
a fluorophore, we were able to detect a variety of anabolic steroid analytes with 100% 
differentiation between structurally similar analytes and micromolar level limits of 
detection. Overall, these results show significant potential in the development of practical, 
fluorescence-based steroid detection devices. 
INTRODUCTION 
The detection of steroids using sensitive, selective, and portable methods is of significant 
interest in a variety of contexts, particularly in athletic and sporting scenarios in which 
illegal anabolic steroid use has been reported.1 Such illegal use has been increasing in 
recent years at all levels, including in youth athletic programs, and the lack of effective 
methods for steroid detection means that the usage is likely to increase unless a rapid, 
sensitive, selective, and easy-to-use method is developed.2 Detection methods that 
currently exist suffer from a variety of drawbacks,3 including the need for expensive 
laboratory instrumentation and significant sample preparation prior to analysis, that make 
them impractical for on-site usage at sporting events.4 As such, a new method is needed. 
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One approach to a fundamentally new detection method has been developed by the Levine 
group in recent years, and relies on the use of cyclodextrin as a supramolecular scaffold to 
promote proximity-induced interactions between the analyte of interest and a high quantum 
yield fluorophore that leads to effective fluorescence detection.5 Such detection has been 
demonstrated for a variety of analytes, including polycyclic aromatic hydrocarbons,6 
bisphenols,7 pesticides,8,9 and alcohols,10 and in a variety of contexts, including in the 
complex matrices of human breast milk,11 urine,7 and saliva.12 High detection sensitivity 
and selectivity has also been demonstrated, and is maintained even in the aforementioned 
complex biological matrices. The fact that the read-out signal of such sensors is a rapid and 
measurable change in the fluorescence emission signal means that such a system is easily 
translatable for on-site measurements. The use of such a fluorescence-based detection 
system for steroid detection has not been reported to date, despite the advantages of the 
system and the known challenges with effective steroid detection. 
Reported herein is the cyclodextrin-promoted fluorescence detection of five anabolic 
steroids: mesterolone, oxandrolone, oxymesterolone, trenbolone, and stanozolol 
(compounds 1-5, Figure 1). When these analytes are combined with cyclodextrin hosts and 
Rhodamine 6G (compound 6), highly sensitive, analyte-specific changes in the 
fluorescence emission of the fluorophore results. Particularly promising results were seen 
using β-cyclodextrin (β-CD) and its derivatives, methyl-β-cyclodextrin (Me-β-CD) and 2-
hydroxypropyl-β-cyclodextrin (2-HP-β-CD), as the supramolecular hosts with Rhodamine 
6G as the fluorophore signaling element, with limits of detection as low as 0.05 μM 
obtained and 100% success in separating the signals obtained from the five steroid analytes 
using linear discriminant analysis. Overall, these results provide a promising proof-of-
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concept for successful steroid detection using cyclodextrin-promoted fluorescence changes 
and indicate that such a system can eventually be used for on-site detection of illegal doping 
in competitive sporting scenarios. 
EXPERIMENTAL SECTION 
Materials and Methods. The anabolic steroid analytes, buffer chemicals, Rhodamine 6G, 
tetrahydrofuran (THF), and dimethyl sulfoxide (DMSO)-d6 were obtained from Sigma-
Aldrich Chemical company and the cyclodextrins were obtained from Tokyo Chemical 
Industry. All chemicals were used as received without further purification. All fluorescence 
measurements were performed using a Shimadzu RF 6000 spectrophotometer. The 
excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were 
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays 
were generated using SYSTAT Version 13.1. NMR studies were conducted using a Bruker 
400 MHz NMR and spectra were analyzed using MestReNova 14.1 software. Electrostatic 
potential map models were generated using Spartan ’18 software. 
Fluorescence Modulation Experiments In six 15 mL glass vials, 100.0 µL of fluorophore 
6 solution (0.1 mg/mL) in THF, 2.00 mL of a 10 mM cyclodextrin solution in citrate buffer 
and 0.400 mL 0.1 M citrate buffer were combined. These solutions were left to stabilize 
for 48 hours in a dark drawer and then transferred into a quartz cuvette. To the first cuvette, 
5.00 µL of analyte 1 was added, in the second cuvette, 5.00 µL of analyte 2 was added, and 
so on until analyte 5 was added to a cuvette. 5.00 µL of THF was added to the last cuvette 
as a control. The solutions were excited at 490 nm and the fluorescence spectra were 
recorded from 500-800 nm. This was repeated for each cyclodextrin solution as well as in 
a cyclodextrin-free control, where citrate buffer was used instead of a cyclodextrin 
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solution. The entire procedure was then repeated using 10.00 µL and 20.00 µL additions 
of analyte instead of 5.00 µL additions. All captured fluorescence spectra were integrated 
vs. wavenumber on the X-axis. The fluorescence modulation of each analyte was 
determined using Equation 1, below: 
Fluorophore Ratio = Flanalyte / Flblank                                (Eq. 1) 
where Flanalyte represents the integrated fluorescence emission of the fluorophore in the 
presence of the analyte, and Flblank represents the integrated fluorescence emission of the 
fluorophore in the absence of analyte. All trials were repeated four times and the reported 
modulation values represent the average of those repeated trials with the standard deviation 
values from those trials included as well. 
Limit of Detection Experiments The limit of detection (LOD), defined as the lowest 
concentration of the analyte that can be detected, and the limit of quantification (LOQ), 
defined as the lowest concentration of analyte that can be reliably quantified were also 
calculated. The limit of detection and quantification experiments were obtained using the 
calibration curve method, following literature-reported procedures.13,14 Limit of detection 
and limit of quantification experiments were done with sequential 5 µL additions of 
analyte, to the same initial solution matrix described in the fluorescence modulation 
experiments (see ESI for more details).  
Array Generation Experimental Details Arrays were generated using SYSTAT 13 
statistical computing software with the following settings9: (a) Classical discriminant 
analysis, (b) Grouping variable: Analytes, (c) Predictors: β-cyclodextrin (β-CD), methyl-
β-cyclodextrin (Me-β-CD), and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD), and (d) 
Long-range statistics: Mahal. These experiments were then repeated using only two 
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predictors instead of all three, and the results of array-based analysis for each pair of 
predictors are also reported herein. 
Computational Experiments Spartan ’18 was used to calculate the equilibrium values of 
the analytes in their ground-state electric potential surfaces using a semi-empirical PM3 
model for each analyte. 
1H NMR Titration Experiments All analytes and cyclodextrin solutions were prepared at a 
concentration of 10 mM in deuterated DMSO (dimethyl sulfoxide-d6). Trials with a total 
volume of 0.50 mL were prepared in Wilmad precision NMR tubes by combining varying 
ratios of analyte to the β-CD solution (see ESI for more details). A 1H NMR spectrum was 
taken of each using a Bruker 400 MHz NMR. These NMR spectra were analyzed for 
shifting and broadening of peaks using MestReNova software.  
RESULTS AND DISCUSSION 
Selection of Analytes and Fluorophore The selected anabolic steroids were selected 
because they are included in the lists of banned and misused substances in athletic 
competitions,15 and because of their significant structural similarities derived from their 
synthesis from testosterone.16 Fluorophore 6 was chosen due to its efficiency in 
fluorescence based detection systems, which has been proven and reported both by this 
group8,17 and others.18,19 
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Figure 41: Structure of anabolic analytes [Mesterolone (compound 1); Oxandrolone 
(compound 2); Oxymetholone (compound 3); Stanozolol (compound 4); and Trenbolone 
(compound 5)] and Rhodamine 6G fluorophore (compound 6) 
 
Selection of Cyclodextrin Hosts Cyclodextrins were chosen as the supramolecular hosts in 
this study because of their known ability to interact with various guest molecules, including 
steroids,20–22 due to their ability to promote non-covalent intermolecular interactions 
including hydrogen bonding, hydrophobic interactions in the interior cavity, and van der 
Waals interactions.23–26 β-cyclodextrin in particular has a well-documented ability to bind 
a variety of hydrophobic analytes, including steroids with significant structural similarity 
to analytes 1-5.10,27–30  α-Cyclodextrin and γ-cyclodextrin, by contrast, with average cavity 
diameters of 5.2 Å and 8.4 Å, respectively, were determined to have non-ideal size matches 
with analytes of average diameters of 5.6 Å.31 The two derivatives of β-cyclodextrin 
selected, methyl-β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin, have significant 
structural similarities to the unmodified analogue, but their notable differences in 
hydrophobicity, solubility, and steric accessibility means that the binding of analytes 1-5 
in these derivatives is expected to differ from binding in the unmodified β-cyclodextrin 
host.32–37 As a result, the use of three different supramolecular hosts was expected to lead 
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to selectivity in array-based linear analysis, an expectation that was successfully borne out 
in experiments (vide infra).6,38 
Fluorescence Modulation Experiments In order to show that each steroid is capable of 
inducing a measurable change in fluorescence emission that is unique for each host-steroid-
fluorophore combination, fluorescence modulation experiments were performed with each 
analyte-cyclodextrin combination, together with control trials run in the absence of a 
cyclodextrin host. Small amounts of the steroids in THF were added to a solution of 
cyclodextrin and fluorophore 6 that had been left to stabilize for 48 hours. The fluorescence 
emission of the fluorophore was measured at an excitation wavelength of 490 nm and 
compared to the fluorescence emission spectra of the fluorophore after the addition of 5 
µL, 10 µL, and 20 µL of the analytes. The degree of fluorescence modulation of the curves 
is the ratio of the fluorescence emission without analyte to the fluorescence emission of the 
fluorophore with analyte, calculated according to Equation 1. The results of the analyte-
induced fluorescence modulation obtained after adding 20 µL of steroid solution are 
summarized in Table 1 and Figure 2, below. 
 
Table 34. Fluorescence ratios obtained for the addition of analytes 1-5 with various 
cyclodextrins in the presence of fluorophore 6a 
Analyte β-CD Me-β-CD 2-HPCD No CD 
1 0.948 ± 0.001 0.932 ± 0.000 0.892 ± 0.000 0.994 ± 0.001 
2 0.974 ± 0.001 0.966 ± 0.001 0.947 ± 0.000 0.987 ± 0.000 
3 0.978 ± 0.001 0.954 ± 0.000 0.955 ± 0.000 1.004 ± 0.003 
4 0.975 ± 0.000 0.986 ± 0.001 0.952 ± 0.000 0.972 ± 0.001 
5 0.975 ± 0.001 0.969 ± 0.001 0.988 ± 0.001 1.036 ± 0.001 
a All values were obtained after the addition of 20 µL of steroid solution. The results were calculated using 
Equation 1 and represent an average of at least four trials. 
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Figure 42. Fluorescence modulation of fluorophore 6 in the presence of all hosts induced 
by 20 µL additions of (A) analyte 1 (B) analyte 2 (C) analyte 3 (D) analyte 4 and (E) analyte 
5. Curves were normalized so that the highest fluorescence intensity for each panel was set 
to 1.0. 
 
These results show that adding various steroid analytes to a cyclodextrin-fluorophore 
solution leads to measurable, analyte-specific fluorescence modulation. In the trials where 
cyclodextrin was present, each analyte induces a unique response, showing a key role for 
the cyclodextrin in enabling fluorescence modulation. In contrast, the cyclodextrin-free 
controls showed minimal fluorescence modulation, with less differences between the 
analytes observed.  Moreover, in the vast majority of cases, the addition of steroid analytes 
caused a decrease in the observed fluorophore emission, represented by a fluorescence 
modulation value less than 1. This decrease is likely due to the fact that the steroids cause 
a displacement of the fluorophore from the cyclodextrin cavity, which increases the 
availability of non-radiative decay pathways and in turn leads to a decrease in fluorescence. 
Analyte 5 in the absence of cyclodextrin represents a notable exception to this trend, and 
57 
may be a result of the reported fluorescence activity of analyte 5,39–42 which can interfere 
with the observed fluorophore emission signal.  
Another way of viewing these analyte-specific changes is through calculating the percent 
differences induced by each analyte when compared to the blank (i.e. analyte-free sample) 
in the same host solution. These values were calculated according to Equation 2, below:  
Percent (%) difference = (1 – Flratio) x 100%                            (Eq. 2) 
where Flratio is the value found in Table 1. The percent differences obtained for each analyte 
in each host-fluorophore solution were calculated, and the results are summarized in Table 
2 and Figure 3, below. 
Table 35.  Percent (%) difference between the fluorescence emission without analyte and 
the fluorescence emission after the addition of analytea 
Analyte β-CD Me-β-CD 2-HP-β-CD No CD 
1 5.235 6.834 10.76 0.566 
2 2.555 3.391 5.265 1.346 
3 2.157 4.639 4.529 -0.444b 
4 2.481 1.362 4.752 2.759 
5 2.542 3.114 1.233 -3.609b 
a Percent difference determined after the addition of 20 µL of analyte, using the fluorescence modulation 
ratios determined in Table 1 and entered into Equation 2 
b Negative values represent a situation where the fluorescence signal with analyte was greater than the signal 
without analyte 
 
Figure 43. The absolute value of the percent difference values from Table 2, grouped by 
(A) the various cyclodextrin hosts and (B) the analytes (compounds 1-5) in solution. 
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Figure 3A groups the percent difference values by hosts, allowing for better visualization 
of which cyclodextrin host facilitates the most modulation of fluorescence. Among the 
various hosts that were investigated, 2-HP-β-CD showed the greatest analyte-induced 
fluorescence modulation overall. This result is likely due to the high aqueous solubility of 
2-HP-β-CD, which provides increased interaction between the cyclodextrin and the analyte 
and increased opportunities for analyte-induced fluorescence modulation. Variability 
between analyte-induced responses was also seen using Me-β-CD, which is likely due to 
the increased hydrophobicity of the cyclodextrin host that facilitates increased analyte-
cyclodextrin interactions and concomitant variations in the observed modulation values. In 
contrast to the two substituted β-cyclodextrin hosts, unmodified β-cyclodextrin showed the 
least analyte-induced fluorescence modulation, which is likely due to a combination of 
limited aqueous solubility and flexibility and a less hydrophobic internal cavity, all of 
which combine to limit the intermolecular interactions between the cyclodextrin and the 
analyte and the resultant analyte-induced fluorescence modulation. As stated previously, 
the control trials without cyclodextrin displayed the lowest average fluorescence 
modulation, highlighting the critical role of cyclodextrin in promoting highly analyte-
specific interactions with the high quantum yield fluorophore.  
Among the various analytes investigated, analyte 1 was able to induce the highest degree 
of fluorescence modulation in the cyclodextrin hosts, whereas analyte 5 induced the lowest 
degree of modulation (Figure 3B). Moreover, analytes 2-4 have a similar, intermediate 
level of analyte-induced modulation when introduced in a cyclodextrin system. Differences 
in analyte-induced responses can be explained with the aid of computed electrostatic 
potential maps, which showing the molecular charge distributions (Figure 4), and the 
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quantitative electrostatic surface values (Table 3), which show minimum and maximum 
electrostatic potentials, dipole moments and polarized surface area. 
 
Figure 44. Spartan-calculated electrostatic potential maps of (A) analyte 1 (B) analyte 2 
(C) analyte 3 (D) analyte 4 and (E) analyte 5. The areas in the dark blue shade corresponds 
to electron-deficient, non-polar regions of the model and scales to the red regions, 
corresponding to the electron-rich, polar regions of the molecule. Color code for the 
molecular models: dark grey: carbon (C), light grey: hydrogen (H), red: oxygen (O), and 
light purple: nitrogen (N). 
 
Table 36.  Quantitative values calculated from the electrostatic potential maps of the 
steroids in Spartan 18’ 
Analyte 
Minimum 
Electrostatic 
Potential (kJ/mol)a 
Maximum 
Electrostatic 
Potential (kJ/mol)b 
Dipole 
Moment (D)c 
Polar 
Surface 
Area (Å2)d 
1 -262.3 114.2 2.11 34.117 
2 -301.9 114.4 5.14 41.129 
3 -262.4 114.1 2.69 48.988 
4 -348.4 123.7 3.69 43.486 
5 -257.9 100.7 2.23 34.214 
a Corresponds to the red, electron-rich regions of the electrostatic potential maps 
b Corresponds to the dark blue, electron-poor regions of the electrostatic potential maps 
c D: abbreviation of the unit debye, dipole moment resulting from two charges of opposite sign but an equal 
magnitude of 10−10 statcoulomb  
d Polar areas that occur due to electronegative elements and hydrogen atoms attached to them in a molecule  
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Overall, the main differences in the analyte structures occurs in the polar, electron-rich 
region on the left side of the molecule, the region where the minimum electrostatic potential 
fluctuates. This potential is used to gauge how reactive different regions of the molecule 
will be in the presence of varying species of molecules (electrophiles, nucleophiles, etc.) 
as well as provide insight into non-covalent intermolecular interactions.43 For example, 
Figure 4A shows the structure of mesterolone (analyte 1) which has one hydroxyl group 
extending from the carbon ring on the left-hand side while Figure 4B illustrates 
oxandrolone (analyte 2), which has an ester in the same region. The minimum electrostatic 
potential energy increases in magnitude from analyte 1 to analyte 2, suggesting that analyte 
2 has greater reactivity towards other species. In analyte 2, this change in structure also 
results in an increased polar surface area, defined as the area on the surface of a molecule 
that is affected by the charge of electronegative atoms and elements such as nitrogen and 
oxygen atoms as well as any hydrogens that are bonded to these elements.44–46 There is 
also a much higher dipole moment, the magnitude of the sum of net charge in a molecule 
based on the combination of nuclear and electron charges, which provides substantial 
insight into chemical reactivities of the species.47,48 The increase in these characteristics 
from analyte 1 to analyte 2 in turn decreases the interaction of analyte 2 with the nonpolar 
binding pocket of the cyclodextrin hosts while the interactions between analyte 1 and the 
nonpolar binding pocket increase. Analytes 3 and 4 have similarly high polar surface areas 
relative to analyte 2, which explains why the analyte-induced modulation caused by analyte 
1 is noticeably higher than those of the other analytes. 
In contrast to analytes 2-4 which show markedly higher dipole moments and polar surface 
areas that explain their decrease modulation values relative to analyte 1, analyte 5 has 
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computed molecular properties that are remarkably similar to those of analyte 1. 
Nonetheless, the differences in how analytes 1 and 5 induce fluorescence modulation are 
substantial, with analyte 1 leading to markedly higher degrees of fluorescence modulation 
(vide supra). Such differences may be explained not by the Spartan computed structural 
information, but by the literature-reported photophysical activity of analyte 5,39–42 which 
can lead to interference with the analyte-induced fluorescence modulation and complicate 
the observed results. NMR was used to investigate the interaction profiles of the analytes 
with β-CD. The only interaction seen was between the analytes and the out rim of the 
cyclodextrin and was indicated by a very slight shift in the two hydroxyl peaks located 
downfield of the aliphatic groups. There was not a large enough shift in spectra to confirm 
covalent bonding, only illustrating the analytes do you not readily enter the cavity of the 
cyclodextrin. Full NMR spectra can be seen in the ESI of this manuscript. 
Array Generation Experiments  
The ability of the analyte-induced fluorescence modulation to provide unique, highly  
selective signals for each analyte was determined through the use of linear discriminant 
analysis (LDA). By using the various cyclodextrin hosts as predictors for the system, we 
determined that each analyte generates an extremely well-separated signal in the LDA 
plots, regardless of whether 5 µL, 10 µL, or 20 µL, a range from 6 µM to just under 30 
µM, of the analyte solution was used (Figure 5). The final concentrations of these analytes 
in the fluorescence modulation trials can be found in the ESI of this manuscript. Of note, 
these plots include tetrahydrofuran (THF) as a control analyte, because that was the solvent 
used in the steroid solutions, and the well-separated signal of the THF indicates that the 
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analytes all induce fluorescence responses that are unique from the response generated by 
their solvent alone.  
 
Figure 45. Arrays generated using the three cyclodextrin hosts as the predictors for the (A) 
5 µL addition trials, (B) 10 µL addition trials and (C) 20 µL addition trials.  
In addition to the well-separated signals between each analyte (apparent via visual 
inspection of Figure 5), introduction of analytes as unknowns into the system after 
classification resulted in 100% accurate classification of the analytes (see ESI for more 
details). Interestingly, as the additions increased in volume, the average cumulative 
proportion of total dispersion, a measure of the separation between signals, also increased. 
The 20 µL trials had an average of 96.7% dispersion while the 5 µL and 10 µL trials had 
an average dispersion of 86.4% and 96.2% dispersion, respectively. This increase in 
dispersion is easily understandable, as higher concentrations of analytes lead to increased 
interactions with the fluorophore-cyclodextrin system and concomitant greater separation 
between signals. 
Due to the differences in the observed cumulative proportions of total dispersion, we 
decided to further investigate system responsiveness to the analytes at the variety of 
concentrations investigated. Linear discriminant analysis of the signals generated from all 
analytes at all concentrations are summarized in Figure 6A (with a THF control signal) and 
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Figure 6B (without the THF control signal included). Of note, although well-separated 
signals were generated for all analytes, the signal for THF in Figure 6A has some overlap 
with the analytes investigated. When the THF signal was eliminated from the analysis, 
100% separation was observed. Moreover, the closely grouped but still well-separated 
points on the plots represent the same analyte at different concentrations, which strongly 
suggests that quantitative analyte determination can also occur. 
 
Figure 46. Arrays of fluorescence modulation data with three different addition volumes 
generated using the cyclodextrin hosts as predictors for all analytes (A) including THF as 
a control analyte; and (B) excluding THF as a control analyte 
Limit Detection and Quantification Experiments 
In addition to determining the ability of the system to selectively distinguish between 
different analytes, the ability of the system to sensitively select analytes at low 
concentrations is critically important in practical detection devices. To that end, the limits 
of detection and limits of quantification were calculated for all analytes in each of the 
cyclodextrin solutions, following literature reported procedures (see ESI for more details), 
and key data is summarized in Table 4.  
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Table 37. Limits of detection (µM) calculated for analytes 1-5 in the cyclodextrin host 
systemsa 
Analyte β-CD Me-β-CD 2-HP-β-CD 
1 17.03 5.300 2.335 
2 11.39 3.886 3.352 
3 8.914 0.148 1.886 
4 7.665 5.981 0.775 
5 6.108 0.049 3.587 
a Values calculated using procedure found in the ESI of this manuscript. All results represent an average of 
at least four trials. 
Overall, the limits of detection using unmodified β-cyclodextrin were higher than the limits 
of detection obtained using the other supramolecular hosts, and reflects both the lower 
modulation values as well as the presumed weaker interactions between β-cyclodextrin and 
the steroid analytes. Of note, all limits of detection reported in Table 4 are markedly lower 
than the known concentrations of steroids found in urine testing following illegal doping 
activities, 49,50 which highlights the potential of this system to be used in practical detection 
applications. 
CONCLUSION 
As illegal doping scandals become more prevalent in practice for athletes in high level 
competition, the need for a rapid on-site detection system grows. The fluorescence 
modulation system introduced herein shows significant promise as a tool for the detection 
of illegal steroids. This system, which relies on cyclodextrin-promoted interactions 
between the target analytes and a high-quantum yield fluorophore, enabled 100% selective 
differentiation between response patterns of the structurally similar anabolic steroids as 
well as different concentrations of the analytes, as well as limits of detection that were 
lower than concentrations reported in illegal doping scenarios. Future research in this area 
will focus on incorporating more analytes as well as transitioning these promising results 
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to a solid-state detection system. Work towards these goals is currently underway in our 
laboratory, and the results of these and other investigations will be reported in due course. 
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MATERIALS AND METHODS 
The anabolic steroid analytes, chemicals required to make buffer solutions, fluorophore 
Rhodamine 6G, and solvent tetrahydrofuran were obtained from Sigma-Aldrich Chemical 
company and the cyclodextrins were obtained from Tokyo Chemical Industry (TCI). All 
chemicals were used as received without further purification. All fluorescence 
measurements were performed using a Shimadzu RF 6000 spectrophotometer. The 
excitation and emission slit widths were set to 3.0 nm. All fluorescence spectra were 
integrated vs. wavenumber on the X-axis using OriginPro 2019 Version 9.60. All arrays 
were generated using SYSTAT Version 13.1. All NMR spectra were taken using a 
Bruker 400 MHz NMR and analyzed with MestReNova 14.1 software.  
DETAILS OF ANALYTES AND FLUOROPHORES 
 
Figure 47: Structure of anabolic analytes (compound 1: Mesterolone; compound 2: 
Oxandrolone; compound 3: Oxymetholone; compound 4: Stanozolol; compound 5: 
Trenbolone) and fluorophore Rhodamine 6G (compound 6) 
All analyte samples were prepared at a concentration of 1.0 mg/mL in THF. The 
fluorophore solution was prepared at a concentration of 0.1 mg/mL in THF. An 0.1 M 
citrate buffer was prepared by combining 2.409 grams of sodium citrate and 0.347 grams 
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of citric acid in a 1.0 L volumetric flask and diluting to the mark with distilled water. The 
pH of the buffer was measured at 6.1, and remained consistent throughout the 
experimental procedures. Cyclodextrin solutions were prepared at a concentration of 10 
mmol in the citrate buffer. The final concentrations of the analytes and fluorophore are 
shown in Table S1, below:  
Table 38: Concentration of analytes and fluorophore in  
solution prior to dilution via sample preparation 
Compound Number Concentration (mM) 
1 3.28 
2 3.26 
3 3.01 
4 3.04 
5 3.62 
6 2.09 
 
EXPERIMENTAL PROCEDURES 
Experimental Procedure for Fluorescence Modulation Experiments 
Fluorescence modulation experiments were done with 5 µL, 10 µL, and 20 µL sequential 
additions of analyte. The fluorescence modulation values for each analyte-cyclodextrin 
combination was determined in the following procedure: 
1. 100 µL of fluorophore 6 solution (0.1 mg/mL) in THF was measured into six 15 
mL glass vials (vial 1 for THF, vial 2 for analyte 1, vial 3 for analyte 2, etc.). 2.00 
mL of a 10 mM cyclodextrin in citrate buffer and 0.40 mL 0.1 M citrate buffer were 
added to each (citrate buffer was at pH 6.1). The vials were capped and left to 
stabilize for 48 hours in a dark drawer. 
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2. After the 48 hours, the contents of one vial and 5.0 µL of analyte were added to the 
cuvette and stirred thoroughly to ensure homogeneity. The solution was excited at 
490 nm and recorded from 500-800 nm. Four repeat measurements were taken. This 
step was repeated for each analyte and an additional time, adding 5.0 µL of THF 
instead of an analyte solution to use as a control. 
3. Step 1 and 2 were repeated for each analyte-cyclodextrin combination (18 trials in 
total). In all cases, the solution was excited at the same wavelength (490 nm) and 
the emission spectra from 500 to 800 nm was recorded four times. 
4. To conduct an experiment with no cyclodextrin present, step 1 was repeated but 
citrate buffer solution was substituted in place of the cyclodextrin solution. The 
contents of the vials were then 100 µL of fluorophore 6 solution and 2.4 mL of 0.1 
M citrate buffer. 
5. After 48 hours, step 2 was repeated using this set of solutions containing no 
cyclodextrin for each analyte. The solutions were excited at the same wavelength 
(490 nm) and the emission spectra from 500 to 800 nm was recorded four times. 
6. Emission spectra were integrated versus wavenumber on the X-axis using 
OriginPro software and fluorescence modulation ratios were determined according 
to Equation 1, below:  
Fluorophore Modulation Ratios = Flanalyte / Flblank                 (Eq.1) 
where Flanalyte represents the integrated fluorescence emission of the fluorophore in 
the presence of the analyte and Flblank represents the integrated fluorescence 
emission of the fluorophore in the absence of the analyte.  
7. These ratios were recorded and are show in Table S4. 
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Step 2 and 5 were repeated with sequential additions for total addition amounts of 10 µL 
and 20 µL of analyte. The final concentrations of the analytes and the fluorophore in 
solution using each of the three addition protocols are summarized in Table S2, below:  
Table 39: Final concentrations (µM) of analytes and fluorophore  
in fluorescence modulation trials 
Compound 5 µL 10 µL 20 µL 
1 6.419 12.81 25.53 
2 6.419 12.81 25.53 
3 5.890 11.76 23.42 
4 5.949 11.88 23.67 
5 7.226 14.42 28.73 
6 8.334 8.317 8.284 
 
Experimental Procedure for Limit of Detection Experiments 
The limit of detection (LOD), defined as the lowest concentration of the analyte that can 
be detected, was obtained using the calibration curve method, following procedures 
reported by Loock et. al.1 The limit of quantification (LOQ) is the lowest concentration of 
analyte that can be reliably and accurately quantified. The limit of detection and 
quantification experiments were conducted following literature-reported procedures.1,2 
LOD experiments were done with sequential 5 µL additions of analyte, according to the 
procedures listed below:  
1. 100 µL of fluorophore 6 solution (0.1 mg/mL) in THF was measured into a 15 mL 
glass vial. 2.00 mL of a 10 mM cyclodextrin in citrate buffer and 0.40 mL 0.1 M 
citrate buffer were added (citrate buffer was at pH 6). The vial was capped and left 
to stabilize for 48 hours. 
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2. The solution was transferred to a quartz cuvette and then excited at 490 nm and the 
fluorescence emission spectra was recorded from 500 to 800 nm. Each fluorescence 
measurement was repeated six times  
3. 5.0 µL of the analyte solution in THF was added to the cuvette and stirred 
thoroughly to ensure homogeneity. The solution was excited at the same 
wavelength (490 nm) and the emission was measured between 500 nm and 800 nm. 
Six repeat measurements were taken. 
4. Step 2 was repeated four times for total addition volumes of 10 µL, 15 µL, 20 µL, 
and 25 µL of the analyte solution. In all cases, the solution was excited at the same 
wavelength (490 nm) and the emission spectra from 500 to 800 nm was recorded 
six times. 
5. Emission spectra were integrated versus wavenumber on the X-axis using 
OriginPro software, and were used to generate calibration curves with analyte 
concentration on the X-axis and integrated fluorescence emission on the Y-axis. 
The curve was fitted with a linear trendline and the equation of the line was 
determined. 
6. The measurements from Step 1, the emission spectra of the combination of the 
Rhodamine solution and β-cyclodextrin solution with no addition of analyte, are 
referred to as the blank in the following calculations. 
7. The limit of the blank (LODblank) is defined according to the following equation: 
LODblank = mblank – 3(SDblank)                                    (Eq. 2) 
where mblank is the mean of the blank integrations and SDblank is the standard 
deviation of those measurements.  
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8. The LODblank was then entered into the equation determined in Step 4 as the y-value. 
The corresponding x-value was calculated. This value is the LOD of the analyte in 
µM in the system. 
9. The LOQ (LOQblank) was calculated in a similar manner to the LOD. The limit of 
quantification of the blank is defined according to the following equation: 
LOQblank = mblank – 10(SDblank).                                  (Eq. 3) 
10. This value is then entered as the y-value from step 4 and the corresponding x-value 
was calculated. This is the value of the LOQ of the analyte for the system in µM. 
All steps were repeated for each analyte-cyclodextrin combination:  
(5 analytes x 3 cyclodextrin solutions = 15 trials). 
The summary tables of these results for each analyte-cyclodextrin combination are shown 
in Tables S4-S6 (vide infra). 
Experimental Procedure for Array Generation Experiments 
Linear discriminant analysis was performed using SYSTAT 13 statistical computing 
software with the following software settings3:  
(a) Classical Discriminant Analysis  
(b) Grouping Variable: Analytes  
(c) Predictors: Cyclodextrin hosts  
(d) Long-Range Statistics: Mahal. 
These experiments were then repeated using only two predictors (i.e. cyclodextrins) instead 
of all three, and the results of array-based analysis for each pair of predictors is reported 
herein as well. 
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Experimental Procedure for Computational Experiments 
Spartan version ’18 was used to calculate the equilibrium molecular conformations of each 
analyte in their ground states in the gas phase using a semi-empirical PM3 model for each 
analyte. This allowed an electrostatic potential map surface to be overlaid over the 
molecules with the mesh overlay function.  
Experimental Procedure for 1H NMR Titration Experiments 
All analytes and β-cyclodextrin solutions were prepared at a concentration of 10 mM in 
deuterated dimethyl sulfoxide (DMSO). 1H NMR samples with total volumes of 0.50 mL 
were prepared in Wilmad precision NMR tubes according to the details listed below: 
Sample 1: β-CD only 
Sample 2: Analyte only 
Sample 3: A molar ratio of 1:2 of analyte to β-CD 
Sample 4: A molar ratio of 1:1 of analyte to β-CD 
Sample 5: A molar ratio of 2:1 of analyte to β-CD. 
These samples were unheated and were at room temperature when spectra were taken. A 
1H NMR spectrum was taken of each using a Bruker 400 MHz NMR. These NMR spectra 
were analyzed using MestReNova 14.1 software. 
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SUMMARY TABLES  
Summary Tables for Fluorescence Modulation Experiments 
Table 40. Fluorescence modulation results obtained for analytes 1-5 with various 
cyclodextrins in the presence of fluorophore 6a 
Addition 
amount 
Analyte β-CD Me-β-CD 2-HPCD No CD 
5 μL 1 0.958 ± 0.001 0.956 ± 0.000 0.905 ± 0.000 1.001 ± 0.001 
 2 0.997 ± 0.001 0.971 ± 0.000 0.957 ± 0.000 0.973 ± 0.001 
 3 1.004 ± 0.001 0.956 ± 0.000 0.966 ± 0.000 1.006 ± 0.001 
 4 0.989 ± 0.003 0.998 ± 0.001 0.906 ± 0.000 0.979 ± 0.001 
 5 0.997 ± 0.001 0.978 ± 0.001 0.999 ± 0.001 1.047 ± 0.001 
10 μL 1 0.950 ± 0.000 0.938 ± 0.000 0.900 ± 0.000 1.004 ± 0.001 
 2 0.990 ± 0.001 0.967 ± 0.000 0.953 ± 0.000 0.990 ± 0.000 
 3 0.988 ± 0.001 0.955 ± 0.000 0.962 ± 0.000 1.009 ± 0.001 
 4 0.985 ± 0.002 0.995 ± 0.000 0.901 ± 0.000 0.969 ± 0.002 
 5 0.992 ± 0.001 0.975 ± 0.001 0.992 ± 0.000 1.040 ± 0.000 
20 μL 1 0.948 ± 0.001 0.932 ± 0.000 0.892 ± 0.000 0.994 ± 0.001 
 2 0.974 ± 0.001 0.966 ± 0.001 0.947 ± 0.000 0.987 ± 0.000 
 3 0.978 ± 0.001 0.954 ± 0.000 0.955 ± 0.000 1.004 ± 0.003 
 4 0.975 ± 0.000 0.986 ± 0.001 0.952 ± 0.000 0.972 ± 0.001 
 5 0.975 ± 0.001 0.969 ± 0.001 0.988 ± 0.001 1.036 ± 0.001 
a All values were calculated using Equation S1, and results reported represent an average 
of at least four trials. 
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Summary Tables for Limit of Detection Experiments 
Table 41. Summary table for limits of detection experiments with β-CDa,b 
Analyte LOD (μM) LOQ (μM) Equation R² 
1 17.03 46.58 y = -1292.6693x + 2133565.2492 0.8369 
2 11.39 35.32 y = -2079.0320x + 2229038.8629 0.9589 
3 8.914 21.42 y = -2559.6708x + 2233461.8386 0.9308 
4 7.665 30.49 y = -2237.8468x + 2220576.1935 0.9776 
5 6.108 24.35 y = -2308.8616x + 2241047.0782 0.9498 
a All LOD values were calculated using Equation 2. 
a All LOQ values were calculated using Equation 3. 
Table 42. Summary table for limits of detection experiments with Me-β-CDa,b 
Analyte LOD (μM) LOQ (μM) Equation R² 
1 5.300 11.72 y = -27374.1167x + 31229827.0035 0.8451 
2 3.886 18.34 y = -11127.1906x + 31855034.7259 0.9193 
3 0.148 4.102 y = -9482.3445x + 31383949.2786 0.8929 
4 5.981 18.21 y = -16056.2718x + 32744010.5956 0.9379 
5 0.049 4.586 y = -21626.3876x + 32220132.7800 0.9755 
a All LOD values were calculated using Equation 2. 
a All LOQ values were calculated using Equation 3. 
Table 43. Summary table for limits of detection experiments with 2-HPCDa,b 
Analyte LOD (μM) LOQ (μM) Equation R² 
1 2.335 7.129 y = -18245.1311x + 26534054.7777 0.9956 
2 3.352 14.66 y = -12790.4792x + 28037979.4349 0.9657 
3 1.886 8.361 y = -21071.8113x + 28366093.4431 0.9945 
4 0.775 3.371 y = -10283.4719x + 26474157.9172 0.8972 
5 3.587 11.53 y = -11788.1436x + 29202530.0773 0.9438 
a All LOD values were calculated using Equation 2. 
a All LOQ values were calculated using Equation 3. 
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Summary Tables for Array Generation Experiments 
With 5 µL analyte additions 
Table 44. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
 
Table 45. Linear discriminant analysis results using β-CD and Me-β-CD as predictors 
 
 
Table 46. Linear discriminant analysis results using β-CD and 2-HPCD as predictors 
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Table 47. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors 
 
 
With 10 µL analyte additions 
Table 48. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
 
Table 49. Linear discriminant analysis results using β-CD and Me-β-CD as predictors 
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Table 50. Linear discriminant analysis results using β-CD and 2-HPCD as predictors 
 
 
Table 51. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors 
 
 
With 20 µL analyte additions 
Table 52. Linear discriminant analysis results using β-CD, Me-β-CD, and 2-HPCD as 
predictors 
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Table 53. Linear discriminant analysis results using β-CD and Me-β-CD as predictors 
 
 
Table 54. Linear discriminant analysis results using β-CD and 2-HPCD as predictors 
 
 
Table 55. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors 
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All Additions with THF 
Table 56. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
 
All Additions excluding THF 
Table 57. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
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SUMMARY FIGURES  
Summary Figures for Individual Fluorescence Modulation Experiments using 
fluorophore 6 
With 5 µL analyte addition 
β-CD 
 
Figure 48. Fluorescence modulation of analyte 1 in the presence of β-CD 
 
Figure 49. Fluorescence modulation of analyte 2 in the presence of β-CD 
 
Figure 50. Fluorescence modulation of analyte 3 in the presence of β-CD 
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Figure 51. Fluorescence modulation of analyte 4 in the presence of β-CD 
 
 
Figure 52. Fluorescence modulation of analyte 5 in the presence of β-CD 
 
Me-β-CD 
 
 
Figure 52. Fluorescence modulation of analyte 1 in the presence of Me-β-CD 
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Figure 53. Fluorescence modulation of analyte 2 in the presence of Me-β-CD 
 
 
Figure 54. Fluorescence modulation of analyte 3 in the presence of Me-β-CD 
 
 
Figure 55. Fluorescence modulation of analyte 4 in the presence of Me-β-CD 
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Figure 56. Fluorescence modulation of analyte 5 in the presence of Me-β-CD 
 
2-HPCD 
 
 
Figure 57. Fluorescence modulation of analyte 1 in the presence of 2-HPCD 
 
 
Figure 58. Fluorescence modulation of analyte 2 in the presence of 2-HPCD 
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Figure 59. Fluorescence modulation of analyte 3 in the presence of 2-HPCD 
 
 
Figure 60. Fluorescence modulation of analyte 4 in the presence of 2-HPCD 
 
 
Figure 61. Fluorescence modulation of analyte 5 in the presence of 2-HPCD 
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No CD 
 
 
Figure 62. Fluorescence modulation of analyte 1 in the presence of no CD 
 
 
Figure 63. Fluorescence modulation of analyte 2 in the presence of no CD 
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Figure 64. Fluorescence modulation of analyte 3 in the presence of no CD 
 
 
Figure 65. Fluorescence modulation of analyte 4 in the presence of no CD 
 
Figure 66. Fluorescence modulation of analyte 5 in the presence of no CD 
 
With 10 µL analyte addition 
β-CD 
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Figure 67. Fluorescence modulation of analyte 1 in the presence of β-CD 
 
Figure 68. Fluorescence modulation of analyte 2 in the presence of β-CD 
 
 
Figure 69. Fluorescence modulation of analyte 3 in the presence of β-CD 
 
 
Figure 70. Fluorescence modulation of analyte 4 in the presence of β-CD 
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Figure 71. Fluorescence modulation of analyte 5 in the presence of β-CD 
 
Me-β-CD 
 
 
Figure 72. Fluorescence modulation of analyte 1 in the presence of Me-β-CD 
 
 
Figure 73. Fluorescence modulation of analyte 2 in the presence of Me-β-CD 
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Figure 74. Fluorescence modulation of analyte 3 in the presence of Me-β-CD 
 
 
Figure 75. Fluorescence modulation of analyte 4 in the presence of Me-β-CD 
 
 
Figure 76. Fluorescence modulation of analyte 5 in the presence of Me-β-CD 
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2-HPCD 
 
 
Figure 77. Fluorescence modulation of analyte 1 in the presence of 2-HPCD 
 
 
Figure 78. Fluorescence modulation of analyte 2 in the presence of 2-HPCD 
 
 
Figure 79. Fluorescence modulation of analyte 3 in the presence of 2-HPCD 
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Figure 80. Fluorescence modulation of analyte 4 in the presence of 2-HPCD 
 
 
Figure 81. Fluorescence modulation of analyte 5 in the presence of 2-HPCD 
No CD 
 
 
Figure 82. Fluorescence modulation of analyte 1 in the presence of no CD 
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Figure 83. Fluorescence modulation of analyte 2 in the presence of no CD 
 
 
Figure 84. Fluorescence modulation of analyte 3 in the presence of no CD 
 
 
Figure 85. Fluorescence modulation of analyte 4 in the presence of no CD 
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Figure 86. Fluorescence modulation of analyte 5 in the presence of no CD 
 
With 20 µL analyte addition 
β-CD 
 
Figure 87. Fluorescence modulation of analyte 1 in the presence of β-CD 
 
 
Figure 88. Fluorescence modulation of analyte 2 in the presence of β-CD 
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Figure 89. Fluorescence modulation of analyte 3 in the presence of β-CD 
 
 
Figure 90. Fluorescence modulation of analyte 4 in the presence of β-CD 
 
 
Figure 91. Fluorescence modulation of analyte 5 in the presence of β-CD 
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Me-β-CD 
 
Figure 92. Fluorescence modulation of analyte 1 in the presence of Me-β-CD 
 
 
Figure 93. Fluorescence modulation of analyte 2 in the presence of Me-β-CD 
 
 
Figure 94. Fluorescence modulation of analyte 3 in the presence of Me-β-CD 
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Figure 95. Fluorescence modulation of analyte 4 in the presence of Me-β-CD 
 
 
Figure 96. Fluorescence modulation of analyte 5 in the presence of Me-β-CD 
 
2-HPCD 
 
 
Figure 97. Fluorescence modulation of analyte 1 in the presence of 2-HPCD 
102 
 
Figure 98. Fluorescence modulation of analyte 2 in the presence of 2-HPCD 
 
 
Figure 99. Fluorescence modulation of analyte 3 in the presence of 2-HPCD 
 
 
Figure 100. Fluorescence modulation of analyte 4 in the presence of 2-HPCD 
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Figure 101. Fluorescence modulation of analyte 5 in the presence of 2-HPCD 
 
No CD 
 
 
Figure 102. Fluorescence modulation of analyte 1 in the presence of no CD 
 
 
Figure 103. Fluorescence modulation of analyte 2 in the presence of no CD 
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Figure 104. Fluorescence modulation of analyte 3 in the presence of no CD 
 
 
Figure 105. Fluorescence modulation of analyte 4 in the presence of no CD 
 
 
Figure 106. Fluorescence modulation of analyte 5 in the presence of no CD 
 
  
105 
Summary Figures for Combined Fluorescence Modulation Experiments using 
Fluorophore 6 
 
 
Figure 107. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of THF (B) 
10 µL of THF (C) 20 µL of THF in the presence of all hosts 
 
 
Figure 108. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 1 
(B) 10 µL of analyte 1 (C) 20 µL of analyte 1 in the presence of all hosts 
 
 
Figure 109. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 2 
(B) 10 µL of analyte 2 (C) 20 µL of analyte 2 in the presence of all hosts 
 
A B C 
   A B C 
A B C 
106 
 
Figure 110. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 3 
(B) 10 µL of analyte 3 (C) 20 µL of analyte 3 in the presence of all hosts 
 
 
Figure 111. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 4 
(B) 10 µL of analyte 4 (C) 20 µL of analyte 4 in the presence of all hosts 
 
 
Figure 112. Fluorescence modulation of fluorophore 6 induced by: (A) 5 µL of analyte 5 
(B) 10 µL of analyte 5 (C) 20 µL of analyte 5 in the presence of all hosts 
  
A B C 
A B C 
A B C 
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Summary Figures for Limit of Detection (LOD) Experiments 
Experiments were carried out with 5 µL sequential additions of analytes with fluorophore 
6 in the presence of all cyclodextrin hosts. 
LOD calibration curves of analytes in presence of β-CD and fluorophore 6  
 
Figure 113. LOD calibration curve of analyte 1 
 
Figure 114. LOD calibration curve of analyte 2 
 
Figure 115. LOD calibration curve of analyte 3 
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Figure 116. LOD calibration curve of analyte 4 
 
 
Figure 117. LOD calibration curve of analyte 5 
 
LOD calibration curves of analytes in presence of Me-β-CD and fluorophore 6 
 
 
Figure 118. LOD calibration curve of analyte 1 
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Figure 119. LOD calibration curve of analyte 2 
 
 
Figure 120. LOD calibration curve of analyte 3 
 
 
Figure 121. LOD calibration curve of analyte 4 
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Figure 122. LOD calibration curve of analyte 5 
 
LOD calibration curves of analytes in presence of 2-HPCD and fluorophore 6 
 
 
Figure 123. LOD calibration curve of analyte 1 
 
 
Figure 124. LOD calibration curve of analyte 2 
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Figure 125. LOD calibration curve of analyte 3 
 
 
Figure 126. LOD calibration curve of analyte 4 
 
 
Figure 127. LOD calibration curve of analyte 5 
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Summary Figures for Array Generation Experiments 
With 5 µL analyte additions 
 
Figure 128. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
Figure 129. Linear discriminant analysis results using β-CD and Me-β-CD as predictors 
 
Figure 130. Linear discriminant analysis results using β-CD and 2-HPCD as predictors 
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Figure 131. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
With 10 µL analyte additions 
 
Figure 132. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
Figure 133. Linear discriminant analysis results using β-CD and Me-β-CD as predictors 
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Figure 134. Linear discriminant analysis results using β-CD and 2-HPCD as predictors
 
Figure 135. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors
With 20 µL analyte additions 
 
Figure 136. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
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Figure 137. Linear discriminant analysis results using β-CD and Me-β-CD as predictors
 
Figure 138. Linear discriminant analysis results using β-CD and 2-HPCD as predictors
 
Figure 139. Linear discriminant analysis results using Me-β-CD and 2-HPCD as predictors 
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All Additions with THF 
  
Figure 140. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
 
All Additions excluding THF 
  
Figure 141. Linear discriminant analysis results with β-CD, Me-β-CD, and 2-HPCD as 
predictors 
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Summary Figures for Computational Experiments 
Spartan ’18 Electrostatic Potential Map Diagrams 
 
 
Figure 142. Electrostatic potential map of analyte 1 in the gas phase at its most stable (i.e. 
“ground state” configuration) 
 
 
Figure 143. Electrostatic potential map of analyte 2 in the gas phase at its most stable (i.e. 
“ground state” configuration) 
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Figure 144. Electrostatic potential map of analyte 3 in the gas phase at its most stable (i.e. 
“ground state” configuration) 
 
Figure 145. Electrostatic potential map of analyte 4 in the gas phase at its most stable (i.e. 
“ground state” configuration) 
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Figure 146. Electrostatic potential map of analyte 5 in the gas phase at its most stable (i.e. 
“ground state” configuration) 
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Summary Figures for NMR Experiments 
Stacked NMR spectra (Full spectra from 0 ppm to 6 ppm) 
 
Figure 147. Stacked NMRs of (A) 2:1 analyte 1:β-cyclodextrin (B) 1:1 analyte 1:β-
cyclodextrin (C) 1:2 analyte 1:β-cyclodextrin (D) analyte 1 and (E) β-cyclodextrin  
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Figure 148. Stacked NMRs of (A) 2:1 analyte 2:β-cyclodextrin (B) 1:1 analyte 2:β-
cyclodextrin (C) 1:2 analyte 2:β-cyclodextrin (D) analyte 2 and (E) β-cyclodextrin  
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Figure 149. Stacked NMRs of (A) 2:1 analyte 3:β-cyclodextrin (B) 1:1 analyte 3:β-
cyclodextrin (C) 1:2 analyte 3:β-cyclodextrin (D) analyte 3 and (E) β-cyclodextrin  
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Figure 150. Stacked NMRs of (A) 2:1 analyte 4:β-cyclodextrin (B) 1:1 analyte 4:β-
cyclodextrin (C) 1:2 analyte 4:β-cyclodextrin (D) analyte 4 and (E) β-cyclodextrin  
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Figure 151. Stacked NMRs of (A) 2:1 analyte 5:β-cyclodextrin (B) 1:1 analyte 5:β-
cyclodextrin (C) 1:2 analyte 5:β-cyclodextrin (D) analyte 5 and (E) β-cyclodextrin  
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Stacked NMR spectra (Zoomed-in spectra from 5.63 ppm to 5.77 ppm) 
 
 
Figure 152. Stacked NMRs of (A) 2:1 analyte 1:β-cyclodextrin (B) 1:1 analyte 1:β-
cyclodextrin (C) 1:2 analyte 1:β-cyclodextrin (D) analyte 1 and (E) β-cyclodextrin  
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Figure 153. Stacked NMRs of (A) 2:1 analyte 2:β-cyclodextrin (B) 1:1 analyte 2:β-
cyclodextrin (C) 1:2 analyte 2:β-cyclodextrin (D) analyte 2 and (E) β-cyclodextrin  
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Figure 154. Stacked NMRs of (A) 2:1 analyte 3:β-cyclodextrin (B) 1:1 analyte 3:β-
cyclodextrin (C) 1:2 analyte 3:β-cyclodextrin (D) analyte 3 and (E) β-cyclodextrin  
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Figure 155. Stacked NMRs of (A) 2:1 analyte 4:β-cyclodextrin (B) 1:1 analyte 4:β-
cyclodextrin (C) 1:2 analyte 4:β-cyclodextrin (D) analyte 4 and (E) β-cyclodextrin  
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Figure 156. Stacked NMRs of (A) 2:1 analyte 5:β-cyclodextrin (B) 1:1 analyte 5:β-
cyclodextrin (C) 1:2 analyte 5:β-cyclodextrin (D) analyte 5 and (E) β-cyclodextrin  
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